<SEC-DOCUMENT>0001213900-24-026676.txt : 20240327
<SEC-HEADER>0001213900-24-026676.hdr.sgml : 20240327
<ACCEPTANCE-DATETIME>20240327172446
ACCESSION NUMBER:		0001213900-24-026676
CONFORMED SUBMISSION TYPE:	POS AM
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20240327
DATE AS OF CHANGE:		20240327

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wearable Devices Ltd.
		CENTRAL INDEX KEY:			0001887673
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POS AM
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-262838
		FILM NUMBER:		24792091

	BUSINESS ADDRESS:	
		STREET 1:		5 HA-TNUFA ST.
		CITY:			YOKNE'AM ILLIT
		STATE:			L3
		ZIP:			2066736
		BUSINESS PHONE:		97246185670

	MAIL ADDRESS:	
		STREET 1:		5 HA-TNUFA ST.
		CITY:			YOKNE'AM ILLIT
		STATE:			L3
		ZIP:			2066736
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS AM
<SEQUENCE>1
<FILENAME>ea0202679-posam_wearable.htm
<DESCRIPTION>POST-EFFECTIVE AMENDMENT NO. 4 TO FORM F-1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>As
filed with the Securities and Exchange Commission on March 27, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Registration
No. 333-262838</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Washington,
DC 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>POST-EFFECTIVE
AMENDMENT NO. 4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FORM&nbsp;F-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WEARABLE
DEVICES LTD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>(Exact
name of registrant as specified in its charter)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>State&nbsp;of&nbsp;Israel</B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3873</B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Not&nbsp;Applicable</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(State&nbsp;or&nbsp;other&nbsp;jurisdiction&nbsp;of</I><BR>
    <I>incorporation&nbsp;or&nbsp;organization)</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Primary&nbsp;Standard&nbsp;Industrial</I><BR>
    <I>Classification&nbsp;Code&nbsp;Number)</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(I.R.S.&nbsp;Employer</I><BR>
    <I>Identification&nbsp;Number)</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5
    Ha-Tnufa St.<BR>
    Yokne&rsquo;am Illit, 2066736 Israel<BR>
    Tel: +972.4.6185670</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: top; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mudra
    Wearable, Inc.<BR>
    24A Trolley Square #2203<BR>
    Wilmington, DE 19806</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Address, including zip
    code, and telephone number,</I></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Name, address, including
    zip code, and telephone</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>including area code,
    of registrant&rsquo;s principal executive offices)</I></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>number, including area
    code, of agent for service)</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Copies
to:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Oded Har-Even,
    Esq. </B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reut Alfiah,
    Adv.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Howard
    Berkenblit, Esq.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Sullivan
    &amp; Worcester LLP</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1633
    Broadway </B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>New
    York, NY 10019</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Tel:
    212.660.3000</B></FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Gal
    Cohen, Adv.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Sullivan
    &amp; Worcester Tel-Aviv (Har-Even &amp; Co.)</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>HaArba&rsquo;a
    Towers</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>28
    HaArba&rsquo;a St.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>North
    Tower, 35th floor</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Tel-Aviv,
    Israel 6473925<BR>
    Tel:&nbsp;+972.74.758.0480</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Approximate
date of commencement of proposed sale to the public: </B>As soon as practicable after the effective date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If any of
the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule&nbsp;415 under the Securities
Act, check the following box.&nbsp;&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If this form
is filed to register additional securities for an offering pursuant to Rule&nbsp;462(b) under the Securities Act, check the following
box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If this form
is a post-effective amendment filed pursuant to Rule&nbsp;462(c) under the Securities Act, check the following box and list the Securities
Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If this form
is a post-effective amendment filed pursuant to Rule&nbsp;462(d) under the Securities Act, check the following box and list the Securities
Act registration statement number of the earlier effective registration statement for the same offering.&nbsp; &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Emerging
growth company&nbsp;&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If an emerging
growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected
not to use the extended transition period for complying with any new or revised financial accounting standards &dagger; provided pursuant
to Section 7(a)(2)(B) of the Securities Act. &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&dagger;
The term &ldquo;new or revised financial accounting standard&rdquo; refers to any update issued by the Financial Accounting Standards
Board to its Accounting Standards Codification after April 5, 2012.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The registrant
hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant
shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance
with Section&nbsp;8(a) of the Securities Act or until the Registration Statement shall become effective on such date as the Commission,
acting pursuant to said Section&nbsp;8(a), may determine.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Explanatory
Note</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
Post-Effective Amendment No. 4, or this Post-Effective Amendment, to the Registration Statement on Form F-1 (File No. 333-262838), or
the Registration Statement, is being filed pursuant to our undertaking in the Registration Statement to update and supplement information
contained in the Registration Statement, as originally declared effective by the Securities and Exchange Commission, or the SEC, on September
12, 2022. The Registration Statement originally covered an offering, or the Offering, of (A) 3,750,000 units, or Units, each consisting
of one ordinary share of the Company, NIS 0.01 par value per share, or Ordinary Shares, and two warrants to purchase one Ordinary Share
each, or each, a Warrant (each with an initial exercise price of $4.00 per Ordinary Share and an exercise price of $2.00 following the
Exercise Price Adjustment, as defined below), in a firm commitment underwritten offering, at a public offering price of $4.25 per Unit,&nbsp;(B)
up to 562,500 additional Ordinary Shares and/or Warrants to purchase up to 1,125,000 Ordinary Shares, issuable to Aegis Capital Corp.,
the underwriter in the Offering, or the Underwriter, solely to cover over-allotments, if any, pursuant to its over-allotment option,
which expired on October 27, 2022, and (C) warrants issued to the Underwriter to purchase up to 187,500 Ordinary Shares, at an exercise
price of $5.31 per Ordinary Share, or the Underwriter&rsquo;s Warrants. This Post-Effective Amendment is being filed to (i) update certain
financial information contained in the Registration Statement, and (ii) cover the sale of Ordinary Shares issuable from time to time
upon exercise of such Warrants and Underwriter&rsquo;s Warrants that remain unexercised as of the date hereof, and include an updated
prospectus related to the offering of Ordinary Shares and Ordinary Shares underlying the Warrants and Underwriter&rsquo;s Warrants that
were registered on the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
refer to the Ordinary Shares, the Warrants, and the Ordinary Shares issued or issuable upon exercise of the Warrants, collectively, as
the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
September 20, 2022, the Company&rsquo;s volume weighted average stock price was less than the exercise floor of $2.00 for the Warrants.
Accordingly, effective after the closing of trading on December 14, 2022 (the 90th calendar day immediately following the issuance date
of the Warrants), the Warrants were adjusted pursuant to their terms, including, but not limited to, to adjust the exercise price of
the Warrants to $2.00, or the Exercise Price Adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
information included in this filing updates the Registration Statement and the prospectus contained therein, or the Prospectus. No additional
securities are being registered under this Post-Effective Amendment. All applicable registration fees were paid at the time of the original
filing of the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: Red">The
information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities
and we are not soliciting an offer to buy these securities in any state or jurisdiction where the offer or sale is not permitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SUBJECT
TO COMPLETION, DATED MARCH 27, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="image_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Wearable
Devices Ltd. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
prospectus relates to the issuance of up to 8,048,361 ordinary shares, NIS 0.01 par value per share, or Ordinary Shares, of Wearable
Devices Ltd., or the Company, upon the exercise of the following warrants, issued by us on September 15, 2022, as part of our initial
public offering, or the IPO: (i) warrants, or the Warrants, to purchase up to 7,860,861 Ordinary Shares, which were exercisable at an
initial exercise price of $4.00 per Ordinary Share (and an exercise price of $2.00 following the Exercise Price Adjustment, as defined
below), and were exercisable immediately upon issuance and expire on September 15, 2027, and (ii) warrants, or the Underwriter&rsquo;s
Warrants, issued to the Underwriter to purchase up to 187,500 Ordinary Shares, which are exercisable at an exercise price of $5.31 per
Ordinary Share, became exercisable beginning on March 12, 2023 and will expire on September 12, 2027.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
refer to the Ordinary Shares, the Warrants, and the Ordinary Shares issued or issuable upon exercise of the Warrants, collectively, as
the securities. See &ldquo;Description of Securities we are Offering&rdquo; for more information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
September 20, 2022, the Company&rsquo;s volume weighted average stock price was less than the exercise floor of $2.00 for the Warrants.
Accordingly, effective after the closing of trading on December 14, 2022 (the 90th calendar day immediately following the issuance date
of the Warrants), the Warrants were adjusted pursuant to their terms, including, but not limited to, to adjust the exercise price of
the Warrants to $2.00, or the Exercise Price Adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Ordinary Shares and Warrants are listed on the Nasdaq Capital Market, or Nasdaq, under the symbols &ldquo;WLDS&rdquo; and &ldquo;WLDSW,&rdquo;
respectively. On March 27, 2024, the last reported sale price of our Ordinary Shares and Warrants on Nasdaq was $[_] per share and $[_]
per warrant, respectively. See &ldquo;Description of Share Capital &mdash; Warrants&rdquo; for additional information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and are subject to reduced
public company reporting requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Investing
in our securities involves a high degree of risk.&nbsp;See &ldquo;Risk Factors&rdquo; beginning on page 1 and &ldquo;Item 3. &mdash;
Key Information &mdash; D. Risk Factors&rdquo; in our Annual Report on Form 20-F for the year ended December 31, 2023, or the 2023 Annual
Report, incorporated by reference in this prospectus for a discussion of the factors you should consider carefully before deciding to
purchase these securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Neither
the Securities and Exchange Commission, or the SEC, nor any state or other foreign securities commission has approved nor disapproved
these securities or determined if this prospectus is truthful or complete.&nbsp;Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The
date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 91%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B>&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_001">Prospectus Summary</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_002">Risk Factors</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_003">Cautionary Note Regarding Forward-Looking
    Statements</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_004">Listing Details</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_005">Use of Proceeds</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_006"><FONT STYLE="font-size: 10pt">Capitalization</FONT></A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_007">Dilution</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_008">Description of Share Capital</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_009">Plan of Distribution</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_010">Expenses</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_011">Legal Matters</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_012">Experts</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_013">Enforceability of Civil Liabilities</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_014">Where You Can Find Additional Information</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_015">Incorporation of Certain Information
    by Reference</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You
should rely only on the information contained in or incorporated by reference into this prospectus and any free writing prospectus prepared
by or on behalf of us or to which we have referred you. We have not authorized anyone to provide you with information that is different.
We are offering to sell the securities, and seeking offers to buy the securities, only in jurisdictions where offers and sales are permitted.
The information in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus
or any sale of the securities. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>For
investors outside of the United States: Neither we nor the underwriter have done anything that would permit this offering or possession
or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You
are required to inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>In
this prospectus, &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; the &ldquo;Company&rdquo; and &ldquo;Wearable Devices&rdquo;
refer to Wearable Devices Ltd. &ldquo;Mudra&rdquo; is a registered trademark of Wearable Devices Ltd.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>All
trademarks or trade names referred to in this prospectus are the property of their respective owners. Solely for convenience, the trademarks
and trade names in this prospectus are referred to without the&nbsp;<SUP>&reg;</SUP>&nbsp;and&nbsp;<SUP>&trade;</SUP>&nbsp;symbols, but
such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable
law, their rights thereto. We do not intend the use or display of other companies&rsquo; trademarks and trade names to imply a relationship
with, or endorsement or sponsorship of us by, any other companies.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Our
reporting currency and functional currency is the U.S. dollar.&nbsp;Unless otherwise expressly stated or the context otherwise requires,
references in this prospectus to &ldquo;NIS&rdquo; are to New Israeli Shekels, and references to &ldquo;dollars&rdquo; or &ldquo;$&rdquo;
mean U.S. dollars.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>This
prospectus, including the documents incorporated by reference, includes statistical, market and industry data and forecasts which we
obtained from publicly available information and independent industry publications and reports that we believe to be reliable sources.
These publicly available industry publications and reports generally state that they obtain their information from sources that they
believe to be reliable, but they do not guarantee the accuracy or completeness of the information.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We
report in accordance with generally accepted accounting principles in the United States, or U.S. GAAP.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="a_001"></A><B>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>This
summary highlights information contained elsewhere in this prospectus. This summary does not contain all of the information you should
consider before investing in our securities. Before you decide to invest in our securities, you should read the entire prospectus carefully,
including the &ldquo;Risk Factors&rdquo; section and the financial statements and related notes appearing at the end of this prospectus.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Our Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are a growth company developing a non-invasive neural input interface in the form of a wearable wristband for controlling digital devices
using subtle touchless finger movements. Since our technology was introduced to the market in 2014, we have been working with both B2B
and B2C customers as part of our push-pull strategy. We are now in the transition phase from research and development to commercialization
of our technology into B2B products. At the same time, we have commenced shipment of the &ldquo;Mudra Band&rdquo;, our first B2C consumer
product, and aftermarket accessory band for Apple Watch that enables gesture control across Apple ecosystem devices such as iPhone, Mac
computer, Apple TV, and iPad, inter alia.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
company&rsquo;s vision is to create a world in which the user&rsquo;s hand becomes a universal input device for touchlessly interacting
with technology. We believe that our technology is setting the standard input interface for the Metaverse. We intend to transform interaction
and control of digital devices to be as natural and intuitive as real-life experiences. We imagine a future in which humans can share
skills, thoughts, emotions, and movements with each other and with computers, using wearable interfaces and devices. We believe that
neural-based interfaces will become as ubiquitous to interact with wearable computing and digital devices in the near future as the touchscreen
is a universal input method for smartphones.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Combining
our own proprietary sensors and AI algorithms into a stylish wristband, our Mudra platform enables users to control digital devices through
subtle finger movements and hand gestures, without physical touch or contact. These digital devices include consumer electronics, smart
watches, smartphones, augmented reality, or AR, glasses, virtual reality, or VR, headsets, televisions, personal computers and laptop
computers, drones, robots, etc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mudra
Development Kit, originally named Mudra Inspire, our B2B development kit product, started selling to B2B customers in 2018 as the first
point of business engagement and contributed to our early-stage revenues. Our early-stage revenues are composed of sales of our Mudra
Inspire and from pilot transactions with several B2B customers. Towards the end of 2023, we commenced the shipments of the &ldquo;Mudra
Band&rdquo;, our first B2C consumer product. In 2023 and 2022, we had revenues of $82 thousand and $45 thousand, respectively, and comprehensive
and net loss of $7.8 million and $6.5 million, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Over
100 companies have purchased our Mudra Inspire development kit, 30 of which are multinational technology companies. These companies are
exploring various input and control use-cases for their products, ranging over multiple countries and industry sectors, including consumer
electronics manufacturers, consumer electronics brands, electronic components manufacturers, IT services and software development companies,
industrial companies, and utility providers. Our objective with these companies is to commercialize the Mudra technology by licensing
it for integration in the hardware and software of these companies&rsquo; products and services. We estimate that there will be a three-to-five-year
period from the time we are first introduced to a customer to signing a licensing agreement. As of March 27, 2024, we have not signed
a license agreement with any of these companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition to consumer electronics, we have recently expanded our brand to include neurotech and brain-computer interface sensors, with
additional verticals that include Industry 4.0 &ndash; a new phase in the Industrial Revolution that focuses on interconnectivity, automation,
machine learning, and real-time data, digital health, sport analytics, and more.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
core of our platform is Mudra, which means &ldquo;gesture&rdquo; in Sanskrit. Mudra&ndash; our surface nerve conductance, or SNC, technology
and wristband tracks neural signals on the user&rsquo;s wrist skin surface, which our algorithms decipher to predict as gestures made
by finger and hand movements. The interface binds each gesture with a specific digital function, allowing users to input commands without
physical touch or contact. Mudra gestures are natural to perform, and gestures can be tailored per a user&rsquo;s intent, desired function,
and the controlled digital device. Mudra can detect multiple gesture types, including hand movements, finger movements, and fingertip
pressure gradations. In addition to the control use-case, our Mudra technology and SNC sensor can be utilized in multiple monitoring
use-cases where we can monitor neural and hand movements for digital health purposes, sport analytics performance, and Industry 4.0 solutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Our Growth
Strategy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
intend to achieve a leading brand position for neural input technology, and to expand our operations to digital and wearable computers.
Key elements of our growth strategy include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offer
                                            a broad range of platform devices.</B> We believe everyone&rsquo;s needs are unique, so we
                                            will offer our users a wide range of connected devices to interact and control in multiple
                                            styles, form factors, and price points, to allow people to find the devices that fit their
                                            lifestyles and goals. We believe that we can leverage the growing public acceptance and awareness
                                            of wearable neural technologies and the rising adoption of wearable devices to market multiple
                                            Mudra-based consumer products.</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Introduce
                                            new features, use-cases, software applications, and services.</B> We plan to continue introducing
                                            new features and services to increase user engagement and revenue. For example, we are investing
                                            in building a diverse user-gesture data bank, which will enable us to develop additional
                                            new gestures. It is our belief that the gestures should be natural for the user and tailored
                                            based on the use-case and controlled device, instead of a &ldquo;one size fits all&rdquo;
                                            approach which forces the user to learn new interactions. In addition to the control use-case,
                                            our Mudra technology and SNC sensor can be utilized in multiple monitoring use-cases where
                                            we can monitor neural and hand movements for digital health purposes, sport analytics performance,
                                            and Industry solutions. The platform serves multiple corporations, businesses and individuals
                                            in the form of customized mobile and computer applications with a broad range of business
                                            models that include hardware sales, licensing, and Software-as-a-Service, or SaaS model.</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Integrate
                                            our Mudra technology into existing devices</B>. We intend to leverage our strong relationships
                                            with multiple consumer electronics companies and brands to sign software and hardware licenses
                                            and royalty contracts to make ourselves a fundamental input component for all digital devices
                                            and platforms. We also believe our superior software and hardware integration ability to
                                            work with companies will enable us to sign agreements with leading global and smaller companies
                                            for consumer devices and industry use-cases.</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Further
                                            penetrate the additional markets.</B> We intend to increase our focus on building relationships
                                            with corporations in Industry 4.0, wellness and digital health, and sports analytics. Our
                                            main advantage is the ability to continuously and securely track the user&rsquo;s engagement
                                            over lengthened periods of times and supply meaningful insights for employee performance
                                            and safety and the user&rsquo;s physiology.</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expand
                                            brand awareness, global distribution and drive sales of our products and services.</B> We
                                            intend to increase our marketing efforts to further expand global awareness of our brand
                                            and drive greater sales of our products and services. The international markets represent
                                            a significant growth opportunity for us, and we intend to expand sales of our products and
                                            services globally through select retailers and strategic partnerships.</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Data
                                            monetization</B>. Once we have a sufficiently large database, we intend to monetize data
                                            derived from a combination of gestures that authenticates a user, identification of patterns
                                            of daily behavior, and monitoring of metrics and identification. This will expand our offerings
                                            related to data and user behavior, which can open multiple new markets and opportunities.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Corporate
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are an Israeli corporation based in Yokne&rsquo;am Illit, Israel and were incorporated in Israel in 2014 under the name Wearable Devices
Ltd. Our principal executive offices are located at 5 Ha-Tnufa St., Yokne&rsquo;am Illit, 2066736 Israel. Our telephone number in Israel
is 972.4.6185670 Our website address is <I>www.wearabledevices.co.il</I>. The information contained on, or that can be accessed through,
our website is not part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Implications
of Being an Emerging Growth Company </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are an &ldquo;emerging growth company,&rdquo; as defined in Section&nbsp;2(a) of the U.S. Securities Act of 1933, as amended, or the
Securities Act, as modified by the JOBS Act. As such, we are eligible to, and intend to, take advantage of certain exemptions from various
reporting requirements applicable to other public companies that are not &ldquo;emerging growth companies&rdquo; such as not being required
to comply with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act.
We could remain an &ldquo;emerging growth company&rdquo; for up to five years, or until the earliest of (a)&nbsp;the last day of the
first fiscal year in which our annual gross revenue exceeds $1.235 billion, (b)&nbsp;the date that we become a &ldquo;large accelerated
filer&rdquo; as defined in Rule&nbsp;12b-2 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, which would occur
if the market value of our Ordinary Shares that is held by non-affiliates exceeds $700&nbsp;million as of the last business day of our
most recently completed second fiscal quarter, or (c)&nbsp;the date on which we have issued more than $1&nbsp;billion in nonconvertible
debt during the preceding three-year period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Implications
of Being a Foreign Private Issuer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are subject to the information reporting requirements of the Exchange Act that are applicable to &ldquo;foreign private issuers,&rdquo;
and under those requirements we file reports with the SEC. As a foreign private issuer, we are not subject to the same requirements that
are imposed upon U.S. domestic issuers by the SEC. Under the Exchange Act, we are subject to reporting obligations that, in certain respects,
are less detailed and less frequent than those of U.S. domestic reporting companies. For example, we are not required to issue quarterly
reports, proxy statements that comply with the requirements applicable to U.S. domestic reporting companies, or individual executive
compensation information that is as detailed as that required of U.S. domestic reporting companies. We also have four months after the
end of each fiscal year to file our annual report with the SEC and are not required to file current reports as frequently or promptly
as U.S. domestic reporting companies. Our officers, directors and principal shareholders are exempt from the requirements to report transactions
in our equity securities and from the short-swing profit liability provisions contained in Section 16 of the Exchange Act. As a foreign
private issuer, we are not subject to the requirements of Regulation FD (Fair Disclosure) promulgated under the Exchange Act. In addition,
as a foreign private issuer, we are permitted to follow certain home country corporate governance practices instead of those otherwise
required under the Nasdaq Stock Market, or Nasdaq, rules for domestic U.S. issuers. See &ldquo;Risk Factors&mdash;Risks Related to the
Ownership of Our Ordinary Shares.&rdquo; These exemptions and leniencies will reduce the frequency and scope of information and protections
available to you in comparison to those applicable to a U.S. domestic reporting company. We intend to take advantage of the exemptions
available to us as a foreign private issuer during and after the period we qualify as an &ldquo;emerging growth company.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>THE
OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuer</B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wearable Devices Ltd. &nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Ordinary
    Shares currently issued</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>and
    outstanding</B></FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,387,428 Ordinary Shares</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ordinary Shares offered by us</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up to 8,048,361 Ordinary Shares issuable upon the exercise
    of (i) Warrants to purchase up to 7,860,861 Ordinary Shares (including Warrants to purchase up to 1,125,000 Ordinary Shares issued
    following the partial exercise of the over-allotment option granted to the Underwriter, in connection with the IPO), and (ii) Underwriter&rsquo;s
    Warrants to purchase up to 187,500 Ordinary Shares. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description of Warrants</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each Warrant has an exercise price of $4.00 per Ordinary
    Share, became exercisable immediately upon issuance and will expire on September 15, 2027. Subject to certain exemptions outlined
    in the Warrant, for a period until two years from the date of issuance of the Warrant, if the Company shall sell, enter into an agreement
    to sell and subsequently sells, or grant any option to purchase, or sell, enter into an agreement to sell and subsequently sells,
    or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or
    other disposition that subsequently closes) any Ordinary Shares or convertible security, at an effective price per share less than
    the exercise price of the Warrant then in effect, or a Dilutive Issuance, the exercise price of the Warrant shall be reduced to equal
    the effective price per share in such Dilutive Issuance;&nbsp;provided, however, that in no event shall the exercise price of the
    Warrant be reduced to an exercise price lower than 50% of the exercise price of the Warrants on the issuance date, or the Initial
    Exercise Price. On the date that is 90 calendar days immediately following the initial issuance date of the Warrants, the exercise
    price of the Warrants will adjust to be equal to the Reset Price, provided that such value is less than the exercise price in effect
    on that date. The Reset Price is equal to the greater of (a) 50% of the Initial Exercise Price of the Warrants on the issuance date
    or (b) 100% of the lowest volume weighted average price per Ordinary Share occurring on any day between the initial exercise date
    of the Warrants and 90 calendar days following the issuance date of the Warrants. The lowest Reset Price is $2.00, which is 50% of
    the Initial Exercise Price. To better understand the terms of the Warrants, you should carefully read the &ldquo;Description of Share
    Capital&rdquo; section of this prospectus. You should also read the form of Warrant, which is filed as an exhibit to the registration
    statement of which this prospectus forms a part. The exercise price adjustments were offered to Warrant holders based on market conditions.
    On September 20, 2022, the Company&rsquo;s volume weighted average stock price was less than the exercise floor of $2.00 for the
    Warrants. Accordingly, effective after the closing of trading on December 14, 2022 (the 90th calendar day immediately following the
    issuance date of the Warrants), the Warrants were adjusted pursuant to their terms, including, but not limited to, to adjust the
    exercise price of the Warrants to $2.00. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underwriter&rsquo;s Warrants</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We issued to the Underwriter Underwriter&rsquo;s Warrants
    to purchase up to 187,500 Ordinary Shares. The Underwriter&rsquo;s Warrants have an exercise price of $5.31 per Ordinary Share, became
    exercisable beginning on March 12, 2023 and will expire on September 12, 2027.&nbsp; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ordinary Shares to be issued and outstanding assuming
    exercise of and outstanding Warrants and Underwriter&rsquo;s Warrants <SUP>(1)</SUP>&nbsp;</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,435,789 Ordinary Shares </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use of proceeds</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will receive up to approximately $15.7 million in
    net proceeds if all Warrants are exercised (assuming an exercise price of $2.00 per Ordinary Share following the Exercise Price Adjustment)
    and up to $996 thousand in net proceeds if all Underwriter&rsquo;s Warrants are exercised. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We currently expect to use the net
    proceeds from the IPO and this offering for the following purposes: </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately $1.95 million to manufacture the Mudra
    Band for Apple Watch product, which includes the purchase of components, manufacturing of components, and assembly of the product;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately $2.4 million to market the Mudra Band
    for Apple Watch and to market additional future consumer products of our B2C product line;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately $3.3 million for the continued research
    and development of our Mudra technology, including the research and development of the Mudra XR wristband, and additional neural
    signals architecture, algorithms and User Experience, or UX;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately $2.1 million for sales and support of
    our B2B customers, and for the integration and licensing our Mudra technology into our B2B customers&rsquo; products;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$300,000 for a cash payment to Alpha Capital Anstalt,
    or Alpha, as compensation for their consent to the IPO; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$840,000 for repayment of a loan from L.I.A. Pure Capital
    Ltd., or Pure Capital; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the remainder for working capital and general corporate
    purposes, including an aggregate of approximately $650 thousand payable to certain of our executive officers as bonuses as a result
    of completion of the IPO.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amounts and schedule of our
    actual expenditures will depend on multiple factors. As a result, our management will have broad discretion in the application of
    the net proceeds of the IPO and this offering.&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk factors</B>&nbsp; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You should read the &ldquo;Risk
    Factors&rdquo; section beginning on page 1 of this prospectus, and &ldquo;Item&nbsp;3. &mdash; Key Information&nbsp;&mdash;&nbsp;D.&nbsp;Risk
    Factors&rdquo; in our 2023 Annual Report, incorporated by reference herein, and other information included or incorporated by reference
    in this prospectus for a discussion of factors to consider carefully before deciding to invest in the Ordinary Shares and Warrants.&nbsp;
    </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nasdaq symbol:&nbsp;</B>&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;WLDS&rdquo; for
    the Ordinary Shares and &ldquo;WLDSW&rdquo; for the Warrants. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: left"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unless
                                            otherwise indicated, the number of Ordinary Shares outstanding prior to and after this offering
                                            is based on 20,387,428 Ordinary Shares outstanding as of March 25, 2024. This number excludes:</FONT></P></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,749,189
        Ordinary Shares issuable upon the exercise of outstanding options allocated or granted to directors, employees and consultants
        under our 2015 Share Option Plan, or the Plan, at a weighted average exercise price of $0.73, of which 1,163,606 were vested
        as of March 25, 2024;&nbsp;</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,205
        Ordinary Shares issuable upon the exercise of warrants issued to a consultant, at an exercise price of $2.25, which are all vested
        as of March 25, 2024, and an additional 23,640 Ordinary Shares issuable upon the exercise of warrants issued to an advisor, at
        an exercise price of $4.23 per Ordinary Share;&nbsp;</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; &nbsp; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,066,637 Ordinary Shares reserved for future issuance
    under our 2015 Plan; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; padding-right: 1.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;
    </FONT></TD>
    <TD STYLE="padding-right: 1.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">671,687 Ordinary Shares
    issuable upon the exercise of warrants issued to certain investors in April 2021 pursuant to their share purchase agreements with
    us, at an exercise price of $5.29 per Ordinary Share.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="a_002"></A><B>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>An
investment in our securities involves a high degree of risk. You should carefully consider the risks set forth under the caption &ldquo;Item
3. Key Information &mdash; D. Risk Factors&rdquo; in our 2023 Annual Report, which is incorporated by reference in this prospectus, together
with all of the other information appearing in this prospectus or incorporated by reference into this prospectus before making an investment
in our securities. Our business, financial condition or results of operations could be materially and adversely affected if any of these
risks occurs and, as a result, the market price of our securities could decline and you could lose all or part of your investment. This
prospectus also contains forward-looking statements that involve risks and uncertainties. See &ldquo;Cautionary Statement Regarding Forward-Looking
Statements.&rdquo; Our actual results could differ materially and adversely from those anticipated in these forward-looking statements
as a result of certain factors.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_003"></A>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Some
of the statements made under &ldquo;Prospectus Summary,&rdquo; &ldquo;Risk Factors,&rdquo; &ldquo;Use of Proceeds,&rdquo; &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations,&rdquo; &ldquo;Business&rdquo; and elsewhere in this prospectus,
including in our 2023 Annual Report incorporated by reference herein, and other information included or incorporated by reference in
this prospectus, constitute forward-looking statements. In some cases, you can identify forward-looking statements by terminology such
as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo;
&ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;predicts,&rdquo; &ldquo;potential&rdquo; &ldquo;intends&rdquo; or &ldquo;continue,&rdquo;
or the negative of these terms or other comparable terminology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">These
forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements
that contain projections of results of operations or of financial condition, expected capital needs and expenses, statements relating
to the research, development, completion and use of our products, and all statements (other than statements of historical facts) that
address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forward-looking
statements are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements
on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current
conditions, expected future developments and other factors they believe to be appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Important
factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking
statements include, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our 2023 Annual Report contained an explanatory paragraph
    regarding substantial doubt about our ability to continue as a going concern, which could prevent us from obtaining new financing
    on reasonable terms or at all.&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SNC becoming the industry standard input method for
    wearable computing and consumer electronics;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain and expand our existing customer
    base; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">timing of the shipment to early-booking orders of our
    Mudra Band;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain and expand compatibility of
    our devices with a broad range of mobile devices and operating systems;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain our business models;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to correctly predict the market growth;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to remediate material weaknesses in our
    internal control over financial reporting;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to retain our founders;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain, protect, and enhance our intellectual
    property;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to raise capital through the issuance of
    additional securities;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the impact of competition and new technologies;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general market, political and economic conditions in
    the countries in which we operate;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">projected capital expenditures and liquidity;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes
                                            in our strategy;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                            ability to comply with Nasdaq listing requirements;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                            global political and economic environment in countries in which we operate including those
                                            related to recent unrest and actual or potential armed conflict in Israel and other parts
                                            of the Middle East, such as the Israel-Gaza Strip war;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation; and </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">those factors referred to in &ldquo;Item 3. Key Information
    &mdash; D. Risk Factors,&rdquo; &ldquo;Item 4. Information on the Company,&rdquo; and &ldquo;Item 5. Operating and Financial Review
    and Prospects,&rdquo; of our 2023 Annual Report as well other factors in the 2023 Annual Report.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">These
statements are only current predictions and are subject to known and unknown risks, uncertainties, and other factors that may cause our
or our industry&rsquo;s actual results, levels of activity, performance or achievements to be materially different from those anticipated
by the forward-looking statements. We discuss many of these risks in this prospectus in greater detail under the heading &ldquo;Risk
Factors&rdquo; and elsewhere in this prospectus and the documents incorporated herein by reference. You should not rely upon forward-looking
statements as predictions of future events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels
of activity, performance, or achievements. Except as required by law, we are under no duty to update or revise any of the forward-looking
statements, whether as a result of new information, future events or otherwise, after the date of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_004"></A>LISTING
DETAILS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Ordinary Shares and Warrants are listed on Nasdaq under the symbols &ldquo;WLDS&rdquo; and &ldquo;WLDSW,&rdquo; respectively. All of
our Ordinary Shares have the same rights and privileges. See &ldquo;Description of Share Capital.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_005"></A>USE
OF PROCEEDS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
will receive up to approximately $15.7 million in net proceeds if all Warrants are exercised (assuming an exercise price of $2.00 per
Ordinary Share following the Exercise Price Adjustment) and up to $996 thousand if all Underwriter&rsquo;s Warrants are exercised.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
currently expect to use the net proceeds from the IPO and this offering for the following purposes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
                                            $1.95&nbsp;million to manufacture the Mudra Band for Apple Watch product, which includes
                                            the purchase of components, manufacturing of components, and assembly of the product;</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
                                            $2.4 million to market the Mudra Band for Apple Watch and to market additional future consumer
                                            products of our B2C product line;</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
                                            $3.3 million for the continued research and development of our Mudra technology, including
                                            the research and development of the Mudra XR wristband, and additional neural signals architecture,
                                            algorithms and User Experience, or UX;</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
                                            $2.1 million for sales and support of our B2B customers, and for the integration and licensing
                                            our Mudra technology into our B2B customers&rsquo; products;</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$300,000
                                            for a cash payment to Alpha, as compensation for their consent to the IPO;</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$840,000
                                            for repayment of a loan from L.I.A. Pure Capital Ltd., or Pure Capital; and</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            remainder for working capital and general corporate purposes, including an aggregate of approximately
                                            $650 thousand payable to certain of our executive officers as bonuses as a result of completion
                                            of the IPO.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changing
circumstances may cause us to consume capital significantly faster than we currently anticipate. The amounts and timing of our actual
expenditures will depend upon numerous factors, including&nbsp;the progress of our global marketing and sales efforts, the development
of our products and the overall economic environment. Therefore, our management will retain broad discretion over the use of the proceeds
from the IPO and this offering. We may ultimately use the proceeds for different purposes than what we currently intend. Pending any
ultimate use of any portion of the proceeds from the IPO and this offering, if the anticipated proceeds will not be sufficient to fund
all the proposed purposes, our management will determine the order of priority for using the proceeds, as well as the amount and sources
of other funds needed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pending
our use of the net proceeds from the IPO and this offering, we may invest the net proceeds in a variety of capital preservation investments,
including short-term, investment grade, interest bearing instruments and U.S. government securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_006"></A>CAPITALIZATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table sets forth our cash and cash equivalents and our capitalization as of December 31, 2023:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on an actual basis; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on an as adjusted basis to give effect to the issuance
    of: (i) up to 7,860,861 Ordinary Shares issuable upon the exercise of the Warrants, for aggregate net proceeds of $15.7 million (assuming
    an exercise price of $2.00 per Ordinary Share following the Exercise Price Adjustment); and (ii) up to 187,500 Ordinary Shares issuable
    upon the exercise of the Underwriter&rsquo;s Warrants, for aggregate net proceeds of $996 thousand, as if such issuances had occurred
    as of December 31, 2023.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">You
should read this table in conjunction with our financial statements as of December 31, 2023 and &ldquo;Item 5. Operating and Financial
Review and Prospects&rdquo;, in our 2023 Annual Report and incorporated by reference herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    of December 31, 2023</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; font-style: italic; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">U.S.
    dollars in thousands</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Actual</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    Adjusted</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">810</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,528</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Long term debt</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">278</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">278</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholders&rsquo; equity:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Share capital</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">57</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">81</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional paid in capital</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,692</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">43,386</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated losses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(21,223</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(21,223</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total shareholders&rsquo;
    equity</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,526</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,244</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total capitalization</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,804</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,522</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
number of Ordinary Shares held by existing shareholders is based on 20,387,428 Ordinary Shares outstanding as of December 31, 2023, and
excludes as of such date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,749,189 Ordinary Shares
    issuable upon the exercise of options allocated or granted to directors, employees and consultants under our share incentive plan,
    at a weighted average exercise price of $0.73, of which 1,118,272 were vested as of December 31, 2023;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,205 Ordinary Shares issuable
    upon the exercise of warrants issued to a consultant at an exercise price of $2.25, which were all vested as of December 31, 2023,
    and an additional 23,640 Ordinary Shares issuable upon the exercise of warrants issued to an advisor, at an exercise price of $4.23
    per Ordinary Share;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; &nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,066,637 Ordinary Shares
    reserved for future issuance under the Plan; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; &nbsp; </FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">671,687 Ordinary Shares issuable
    upon the exercise of warrants issued to certain investors in April 2021 pursuant to their share purchase agreements with us, at an
    exercise price of $5.29 per Ordinary Share.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_007"></A>DILUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
you invest in our securities, your interest will be diluted immediately to the extent of the difference between the price per Ordinary
Share you will pay upon exercise of the Warrants and the as adjusted net tangible book value per Ordinary Share after exercise of all
the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
December 31, 2023 we had a net tangible book value of $5.5 million corresponding to a net tangible book value of $0.27 per Ordinary Share.
Net tangible book value per Ordinary Share represents the amount of our total tangible assets less our total liabilities, divided by
20,387,428, the total number of Ordinary Shares issued and outstanding on December 31, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">After
giving effect to the issuance of up to 7,860,861 Ordinary Shares issued upon the exercise of the Warrants, for aggregate net proceeds
of $15.7 million (assuming an exercise price of $2.00 per Ordinary Share following the Exercise Price Adjustment), and the exercise of
the Underwriter&rsquo;s Warrants, our as adjusted net tangible book value estimated at December 31, 2023 would have been approximately
$22.2 million, representing $0.78 per Ordinary Share. This represents an immediate increase in historical net tangible book value of
$0.51 per Ordinary Share to existing shareholders and an immediate average dilution in net tangible book value of $1.30 per Ordinary
Share to purchasers of Ordinary Shares in this offering.&nbsp;Dilution for this purpose represents the difference between the average
price per Ordinary Share paid by these purchasers and net tangible book value per Ordinary Share immediately after the completion of
this offering.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table illustrates this dilution on a per Ordinary Share basis to investors in this offering:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise price per Warrant</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.00</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise price per Underwriter&rsquo;s Warrant</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.31</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">As adjusted net tangible book value per Ordinary
    Share after this offering</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.78</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dilution per Ordinary Share to new investors</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.30</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Percentage of dilution in net tangible book
    value per Ordinary Share for new investors</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">62.3</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_008"></A>DESCRIPTION
OF SHARE CAPITAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following description of the share capital of Wearable Devices Ltd., or the Company, and the provisions of our articles of association&nbsp;<FONT STYLE="background-color: white">and
Israeli law</FONT>&nbsp;are summaries, do not purport to be complete and is qualified in its entirety by reference to our articles of
association, Israeli law and any other documents referenced.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Type and
class of securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Ordinary
Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of March 25, 2024, our authorized share capital consists of 50,000,000 Ordinary Shares, NIS 0.01 par value per share, of which 20,387,428
Ordinary Shares were issued and outstanding as of such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
of our outstanding Ordinary Shares have been validly issued, fully paid and non-assessable. Our Ordinary Shares are not redeemable and
are not subject to any preemptive right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Ordinary Shares and warrants have been listed on the Nasdaq Capital Market under the symbol &ldquo;WLDS&rdquo; and &ldquo;WLDSW,&rdquo;
respectively, since September 13, 2022.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Warrants
and Options</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of March 25, 2024, we have issued and outstanding Warrants to purchase an aggregate of 7,860,861 Ordinary Shares, with exercise price
of $2.00 per Ordinary Share. The Warrants were issued as part of our IPO and have been listed on the Nasdaq Capital Market under the
symbol &ldquo;WLDSW&rdquo; since September 13, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of March 25, 2024, we have 1,749,189 Ordinary Shares issuable upon the exercise of outstanding options allocated or granted to certain
employees, directors and consultants, under the Plan. An additional 1,066,637 Ordinary Shares are reserved for future issuance under
our 2015 Share Option Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Articles
of Association</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Directors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
board of directors shall direct our policy and shall supervise the performance of our Chief Executive Officer and his actions. Our board
of directors may exercise all powers that are not required under the Israeli Companies Law 5759-1999, or the Companies Law, or under
our articles of association to be exercised or taken by our shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Rights
Attached to Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Ordinary Shares shall confer upon the holders thereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">equal right to attend and to vote at all of our general
    meetings, whether regular or special, with each Ordinary Share entitling the holder thereof, which attend the meeting and participate
    at the voting, either in person or by a proxy or by a written ballot, to one vote;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">equal right to participate in distribution of dividends,
    if any, whether payable in cash or in bonus shares, in distribution of assets or in any other distribution, on a per share pro rata
    basis; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">equal right to participate, upon our dissolution, in
    the distribution of our assets legally available for distribution, on a per share pro rata basis.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B><I>Election
of Directors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to our articles of association, our directors are elected by the general meeting and, unless appointed for a shorter term, serve in office
until the third annual general meeting after the general meeting in which such director was appointed, in which such later annual general
meeting the directors will be brought for re-election or replacement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
each annual general meeting, the election or re-election of directors following the expiration of the term of office of the directors
of that class of directors will be for a term of office that expires on the third annual general meeting following such election or re-election,
such that each year the term of office of only one class of directors will expire, and all other directors whose service term lapsed
shall be deemed to have been re-elected for a term until the next annual general meeting. The director to be deemed and to be re-elected
is the director that served the longest period since its appointment or last re-election. If more than one director served the longest
time, the board of directors will decide which of such directors will be brought for re-election at the relevant general meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Annual
and Special Meetings</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
the Israeli law, we are required to hold an annual general meeting of our shareholders once every calendar year, at such time and place
which shall be determined by our board of directors, that must be no later than 15 months after the date of the previous annual general
meeting. All meetings other than the annual general meeting of shareholders are referred to as special general meetings. Our board of
directors may call special meetings whenever it sees fit and upon the request of: (a) any two of our directors or such number of directors
equal to one quarter of the directors then at office; and/or (b) one or more shareholders holding, in the aggregate, (i) 5% or more of
our outstanding issued shares and 1% of our outstanding voting power or (ii) 5% or more of our outstanding voting power, or the Non Exempted
Holding. However, under new exemption applicable as of March 12, 2024, the board of directors of an Israeli company whose shares are
listed outside of Israel, shall convene a special meeting at the request of: (i) one or more shareholders holding at least ten percent
(10%) of the issued and outstanding share capital instead of five (5%) in the past, and at least one percent (1%) of the voting rights
in the company, or (ii) one or more shareholders holding at least ten percent (10%) of the voting rights in the company, unless the applicable
law incorporated in the country in which the Company is listed for trade, establishes a right to demand convening of such a meeting for
those holding less than ten percent (10%) of the voting rights in the company (in which case, the Non Exempted Holding shall apply).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subject
to the provisions of the Companies Law and the regulations promulgated thereunder, shareholders entitled to participate and vote at general
meetings are the shareholders of record on a date to be decided by the board of directors, which may be between four and sixty days prior
to the date of the meeting. Resolutions regarding the following matters must be passed at a general meeting of our shareholders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">amendments to our articles
    of association; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the exercise of our board of directors&rsquo; powers
    by a general meeting if our board of directors is unable to exercise its powers and the exercise of any of its powers is required
    for our proper management;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointment or termination of our auditors;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointment of directors, including external directors
    (other than with respect to circumstances specified in our articles of association); </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approval of acts and transactions requiring general
    meeting approval pursuant to the provisions of the Companies Law (mainly certain related party transactions) and any other applicable
    law; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increases or reductions
    of our authorized share capital; and </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a merger (as such term
    is defined in the Companies Law). </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Notices</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Companies Law require that a notice of any annual or special shareholders meeting be provided at least 21 days prior to the meeting,
and if the agenda of the meeting includes the appointment or removal of directors, the approval of transactions with office holders or
interested or related parties, approval of the company&rsquo;s general manager to serve as the chairman of the board of directors or
an approval of a merger, notice must be provided at least 35 days prior to the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Quorum</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
permitted under the Companies Law, the quorum required for our general meetings consists of at least two shareholders present in person,
by proxy, written ballot or voting by means of electronic voting system, who hold or represent between them at least 25% of the total
outstanding voting rights. If within half an hour of the time set forth for the general meeting a quorum is not present, the general
meeting shall stand adjourned the same day of the following week, at the same hour and in the same place, or to such other date, time
and place as prescribed in the notice to the shareholders and in such adjourned meeting, if no quorum is present within half an hour
of the time arranged, any number of shareholders participating in the meeting, shall constitute a quorum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">If
a special general meeting was summoned following the request of a shareholder, and within half an hour a legal quorum shall not have
been formed, the meeting shall be canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B><I>Adoption
of Resolutions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
articles of association provide that resolutions amending provisions of the articles of association related to the staggered board of
directors and the composition of the board of directors, as well as a resolution to dismiss a director, will require an affirmative vote
of 70% of the voting power represented at a general meeting and voting thereon. Other than that, and unless otherwise required under
the Companies Law and our articles, all resolutions of the Company&rsquo;s shareholders require a simple majority vote. A shareholder
may vote in a general meeting in person, by proxy, by a written ballot.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B><I>Changing
Rights Attached to Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Unless
otherwise provided by the terms of the shares and subject to any applicable law, any modification of rights attached to any class of
shares must be adopted by the holders of a majority of the shares of that class present a general meeting of the affected class or by
a written consent of all the shareholders of the affected class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">The
enlargement of an existing class of shares or the issuance of additional shares thereof, shall not be deemed to modify the rights attached
to the previously issued shares of such class or of any other class, unless otherwise provided by the terms of the shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B><I>Limitations
on the Right to Own Securities in Our Company</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">There
are no limitations on the right to own our securities in our articles of association. In certain circumstances the Warrants have restrictions
upon the exercise of such warrants if such exercise would result in the holders thereof owning more than 4.99% or 9.99% of our Ordinary
Shares upon such exercise, as further described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B><I>Provisions
Restricting Change in Control of Our Company</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
articles of association provide for a staggered board of directors, which mechanism may delay, defer or prevent a change of control of
the Company&rsquo;s board of directors. Other than that, there are no specific provisions of our articles of association that would have
an effect of delaying, deferring or preventing a change in control of the Company or that would operate only with respect to a merger,
acquisition or corporate restructuring involving us. However, as described below, certain provisions of the Companies Law may have such
effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Companies Law includes provisions that allow a merger transaction and requires that each company that is a party to the merger have the
transaction approved by its board of directors and, unless certain requirements described under the Companies Law are met, a vote of
the majority of shareholders, and, in the case of the target company, also a majority vote of each class of its shares. For purposes
of the shareholder vote of each party, unless a court rules otherwise, the merger will not be deemed approved if shares representing
a majority of the voting power present at the shareholders meeting and which are not held by the other party to the merger (or by any
person or group of persons acting in concert who holds 25% or more of the voting power or the right to appoint 25% or more of the directors
of the other party) vote against the merger. If, however, the merger involves a merger with a company&rsquo;s own controlling shareholder
or if the controlling shareholder has a personal interest in the merger, then the merger is instead subject to the same special majority
approval that governs all extraordinary transactions with controlling shareholders. Upon the request of a creditor of either party to
the proposed merger, the court may delay or prevent the merger if it concludes that there exists a reasonable concern that as a result
of the merger the surviving company will be unable to satisfy the obligations of any of the parties to the merger, and may further give
instructions to secure the rights of creditors. If the transaction would have been approved by the shareholders of a merging company
but for the separate approval of each class or the exclusion of the votes of certain shareholders as provided above, a court may still
approve the merger upon the petition of holders of at least 25% of the voting rights of a company. For such petition to be granted, the
court must find that the merger is fair and reasonable, taking into account the value of the parties to the merger and the consideration
offered to the shareholders. In addition, a merger may not be completed unless at least (1) 50 days have passed from the time that the
requisite proposals for approval of the merger were filed with the Israeli Registrar of Companies by each merging company and (2) 30
days have passed since the merger was approved by the shareholders of each merging company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
term &ldquo;Special Majority&rdquo; hereof will be defined as described in section 275(a)(3) of the Companies Law as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at least a majority of the shares held by shareholders
    who are not controlling shareholders and do not have personal interest in the merger (excluding a personal interest that did not
    result from the shareholder&rsquo;s relationship with the controlling shareholder) have voted in favor of the proposal (shares held
    by abstaining shareholders shall not be considered); or </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the total number of shares voted against the merger,
    does not exceed 2% of the aggregate voting rights of the company. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">The
Companies Law also provides that, subject to certain exceptions, an acquisition of shares in an Israeli public company must be made by
means of a &ldquo;special&rdquo; tender offer if as a result of the acquisition (1) the purchaser would become a holder of 25% or more
of the voting rights in the company, unless there is already another holder of at least 25% or more of the voting rights in the company
or (2) the purchaser would become a holder of 45% or more of the voting rights in the company, unless there is already a holder of more
than 45% of the voting rights in the company. These requirements do not apply if, in general, the acquisition (1) was made in a private
placement that received shareholders&rsquo; approval, subject to certain conditions, (2) was from a holder of 25% or more of the voting
rights in the company which resulted in the acquirer becoming a holder of 25% or more of the voting rights in the company, or (3) was
from a holder of more than 45% of the voting rights in the company which resulted in the acquirer becoming a holder of more than 45%
of the voting rights in the company. A &ldquo;special&rdquo; tender offer must be extended to all shareholders. In general, a &ldquo;special&rdquo;
tender offer may be consummated only if (1) at least 5% of the voting power attached to the company&rsquo;s outstanding shares will be
acquired by the offeror and (2) the offer is accepted by a majority of the offerees who notified the company of their position in connection
with such offer (excluding the offeror, controlling shareholders, holders of 25% or more of the voting rights in the company or anyone
on their behalf, or any person having a personal interest in the acceptance of the tender offer). If a special tender offer is accepted,
then the purchaser or any person or entity controlling it or under common control with the purchaser or such controlling person or entity
may not make a subsequent tender offer for the purchase of shares of the target company and may not enter into a merger with the target
company for a period of one year from the date of the offer, unless the purchaser or such person or entity undertook to effect such an
offer or merger in the initial special tender offer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">If,
as a result of an acquisition of shares, the acquirer will hold more than 90% of an Israeli company&rsquo;s outstanding shares or of
certain class of shares, the acquisition must be made by means of a tender offer for all of the outstanding shares, or for all of the
outstanding shares of such class, as applicable. In general, if less than 5% of the outstanding shares, or of applicable class, are not
tendered in the tender offer and more than half of the offerees who have no personal interest in the offer tendered their shares, all
the shares that the acquirer offered to purchase will be transferred to it by operation of law. However, a tender offer will also be
accepted if the shareholders who do not accept the offer hold less than 2% of the issued and outstanding share capital of the company
or of the applicable class of shares. Any shareholders that was an offeree in such tender offer, whether such shareholder accepted the
tender offer or not, may request, by petition to an Israeli court, (i) appraisal rights in connection with a full tender offer, and (ii)
that the fair value should be paid as determined by the court, for a period of six months following the acceptance thereof. However,
the acquirer is entitled to stipulate, under certain conditions, that tendering shareholders will forfeit such appraisal rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Lastly,
Israeli tax law treats some acquisitions, such as stock-for-stock exchanges between an Israeli company and a foreign company, less favorably
than U.S. tax laws. For example, Israeli tax law may, under certain circumstances, subject a shareholder who exchanges his Ordinary Shares
for shares in another corporation to taxation prior to the sale of the shares received in such stock-for-stock swap.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B><I>Changes
in Our Capital</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">The
general meeting may, by a simple majority vote of the shareholders attending the general meeting:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase our registered share capital by the creation
    of new shares from the existing class or a new class, as determined by the general meeting; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">cancel
    any registered share capital which have not been taken or agreed to be taken by any person;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">consolidate
    and divide all or any of our share capital into shares of larger nominal value than our existing shares;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">subdivide
    our existing shares or any of them, our share capital or any of it, into shares of smaller nominal value than is fixed; and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduce our share capital and any fund reserved for
    capital redemption in any manner, and with and subject to any incident authorized, and consent required, by the Companies Law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Exclusive
Forum</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
articles of association provide that unless the Company consents in writing to the selection of an alternative forum, the federal district
courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising
under the Securities Act&nbsp;of 1933, as amended, or the Securities Act and that any person or entity purchasing or otherwise acquiring
any interest in any security of the Company, shall be deemed to have notice of and consented to this exclusive forum provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Staggered
Board</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
articles of association provide for a split of the board of directors into three classes with staggered three-year terms. At each annual
general meeting of our shareholders, the election or re-election of directors following the expiration of the term of office of the directors
of that class of directors will be for a term of office that expires on the third annual general meeting following such election or re-election,
such that each year the term of office of only one class of directors will expire. The director whom is to be retired and re-elected
shall be the director that served the longest period since its appointment or last re-election or, if more than one director served the
longest time, or if a director who is not to be re-elected agrees to be re-elected, the meeting of the board of directors which sets
the date and agenda for the annual general meeting (acting by a simple majority) will decide which of such directors will be brought
for re-election at the relevant general meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following summary of certain terms and provisions of the Warrants and is subject to, and qualified in its entirety by, the provisions
of the warrant agent agreement between us and VStock Transfer, LLC, as warrant agent, and the form of Warrant, both of which are filed
as exhibits to the 2023 Annual Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Exercisability</I></B><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Warrants are exercisable at any time after their original issuance and at any time up to the date that is five&nbsp;years after their
original issuance. The Warrants will be exercisable, at the option of each holder, in whole or in part by delivering to the Company a
duly executed exercise notice and, at any time a registration statement registering the issuance of the Ordinary Shares underlying the
Warrants under the Securities Act is effective and available for the issuance of such shares, by payment in full in immediately available
funds for the number of Ordinary Shares purchased upon such exercise. If a registration statement registering the issuance of the Ordinary
Shares underlying the Warrants under the Securities Act is not effective or available the holder may, in its sole discretion, elect to
exercise the Warrant through a cashless exercise, in which case the holder would receive upon such exercise the net number of Ordinary
Shares determined according to the formula set forth in the Warrant. No fractional shares will be issued in connection with the exercise
of a Warrant. In lieu of fractional shares, the Company will pay the holder an amount in cash equal to the fractional amount multiplied
by the exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Exercise
Limitation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
holder will not have the right to exercise any portion of the warrant if the holder (together with its affiliates) would beneficially
own in excess of 4.99% of the number of Ordinary Shares outstanding immediately after giving effect to the exercise, as such percentage
ownership is determined in accordance with the terms of the Warrants. However, any holder may increase or decrease such percentage to
any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective until 61&nbsp;days
following notice from the holder to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Exercise
Price</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
exercise price per whole Ordinary Share purchasable upon exercise of the Warrants $4.00 per share. The exercise price is subject to appropriate
adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar
events affecting our Ordinary Shares and also upon any distributions of assets, including cash, stock or other property to our shareholders.
Subject to certain exemptions outlined in the Warrant, for a period until two years from the date of issuance of the Warrant, if the
Company shall sell, enter into an agreement to sell and subsequently sells, or grant any option to purchase, or sell, enter into an agreement
to sell and subsequently sells, or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or
any option to purchase or other disposition the subsequently closes) any Ordinary Shares or convertible security, at an effective price
per share less than the exercise price of the Warrant then in effect, the exercise price of the Warrant shall be reduced to equal the
effective price per share in such Dilutive Issuance;&nbsp;provided, however, that in no event shall the exercise price of the Warrant
be reduced to an exercise price lower than 50% of the Initial Exercise Price. On the date that is 90 calendar days immediately following
the initial issuance date of the Warrants, the exercise price of the Warrants will adjust to be equal to the Reset Price, provided that
such value is less than the exercise price in effect on that date. The Reset Price is equal to the greater of (a) 50% of the Initial
Exercise Price of the Warrants on the issuance date or (b) 100% of the lowest volume weighted average price per Ordinary Share occurring
on any day between the initial exercise date of the Warrants and 90 calendar days following the issuance date of the Warrants. The lowest
Reset Price is $2.00, which is 50% of the Initial Exercise Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
September 20, 2022, the Company&rsquo;s volume weighted average stock price was less than the exercise floor of $2.00 for the Warrants.
Accordingly, effective after the closing of trading on December 14, 2022 (the 90th calendar day immediately following the issuance date
of the Warrants), the Warrants were adjusted pursuant to their terms, including, but not limited to, to adjust the exercise price of
the Warrants to $2.00.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Transferability</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subject
to applicable laws, the Warrants may be offered for sale, sold, transferred or assigned without the Company&rsquo;s consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Warrant
Agent</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Warrants were issued in registered form under a warrant agent agreement between VStock Transfer, LLC, as warrant agent, and the Company.
The Warrants were initially represented only by one or more global warrants deposited with the warrant agent, as custodian on behalf
of The Depository Trust Company, or DTC, and registered in the name of Cede&nbsp;&amp; Co., a nominee of DTC, or as otherwise directed
by DTC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Fundamental
Transactions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
the event of a fundamental transaction, as described in the Warrants and generally including any reorganization, recapitalization or
reclassification of the Ordinary Shares, the sale, transfer or other disposition of all or substantially all of our properties or assets,
our consolidation or merger with or into another person, the acquisition of more than 50% of the Company&rsquo;s outstanding Ordinary
Shares, or any person or group becoming the beneficial owner of 50% of the voting power represented by the Company&rsquo;s outstanding
Ordinary Shares, the holders of the Warrants will be entitled to receive upon exercise of the Warrants the kind and amount of securities,
cash or other property that the holders would have received had they exercised the Warrants immediately prior to such fundamental transaction
without regard to any limitations on exercised contained in the Warrants.&nbsp;The holders of the Warrants may also require the Company
or any successor entity to purchase the Warrants from the holders by paying to the holder an amount in cash (or other types or form of
consideration in special circumstances listed in the Warrant) equal to the Black Scholes value of the remaining unexercised portion of
the Warrant on the date of the fundamental transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Home
Country Practice</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
so long as any of the Warrants remains outstanding, the Company will elect to follow home country practice in lieu of any rules and regulations
of the trading market that would limit the Company&rsquo;s ability to effect the provisions of the Warrants, including but not limited
to shareholder approval rules related to the issuance of securities or adjustment of terms of this Warrant for the benefit of warrant
holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Rights
as a Shareholder</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Except
as otherwise provided in the Warrants or by virtue of such holder&rsquo;s ownership of the Company&rsquo;s Ordinary Shares, the holder
of a Warrant does not have the rights or privileges of a holder of the Company&rsquo;s Ordinary Shares, including any voting rights,
until the holder exercises the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Governing
Law</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Warrants and the warrant agent agreement are governed by New&nbsp;York law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Underwriter&rsquo;s
Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following summary of certain terms and provisions of the Underwriter&rsquo;s Warrant, is subject to, and qualified in its entirety by,
the provisions of the form of Underwriter&rsquo;s Warrant which was filed as an exhibit to the 2023 Annual Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
part of our IPO on the Nasdaq Capital Market, we issued the Underwriter&rsquo;s warrant to the underwriter. The Underwriter&rsquo;s Warrants
are exercisable at $5.31 per Ordinary Share,&nbsp;became exercisable beginning on March 12, 2023 and will expire on September 12, 2027.
The Underwriter&rsquo;s Warrants have been deemed compensation by FINRA and were therefore subject to a six-month lock-up&nbsp;pursuant
to Rule&nbsp;5110 of FINRA.&nbsp;Furthermore, such Underwriter&rsquo;s Warrants shall be exercisable on a cash basis, provided that if
a registration statement registering the ordinary shares underlying the Underwriter&rsquo;s Warrants is not effective, the Underwriter&rsquo;s
Warrants may be exercised on a cashless basis and have anti-dilution terms that are consistent with FINRA Rule 5110(g)(8)(E) and (F).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_009"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
prospectus relates to the issuance of up to 8,048,361 Ordinary Shares upon the exercise of the following warrants, issued by us on September
15, 2022 as part of our IPO: (i) Warrants to purchase up to 7,860,861 Ordinary Shares (including Warrants to purchase up to 1,125,000
Ordinary Shares issued following the partial exercise of the over-allotment option granted to the Underwriter, in connection with the
IPO) , and (ii) Underwriter&rsquo;s Warrants issued to the Underwriter to purchase up to 187,500 Ordinary Shares. The ongoing offer and
sale by us of the Ordinary Shares issuable upon exercise of the Warrants and Underwriter&rsquo;s is being made pursuant to this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
will deliver Ordinary Shares upon exercise of the Warrants and Underwriter&rsquo;s Warrants. We will not issue fractional Ordinary Shares.
Each Warrant contains instructions for the exercise of such Warrant. In order to exercise a Warrant, the holder must deliver the information
required by the applicable warrant agreement, along with payment of the exercise price, if the exercise price is being paid in cash,
for the Ordinary Shares to be purchased. We will then deliver our Ordinary Shares in the manner described in the applicable warrant agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aegis
Capital Corp., or Aegis, acted as the sole book-running manager of the IPO. Under the terms of an underwriting agreement we entered with
Aegis dated September 12, 2022, we granted Aegis an option to purchase from us, at the public offering price, less the underwriting discounts
and commissions, up to 562,500 additional Ordinary Shares and/or up to 1,125,000 over-allotment Warrants, which expired on October 27,
2022, to cover over-allotments, if any. On September 13, 2022, the Underwriter partially exercised the over-allotment option with respect
to Warrants to purchase up to 1,125,000 Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
additional compensation to Aegis, we issued to Aegis Underwriter&rsquo;s Warrants to purchase up to 187,500 Ordinary Shares (5.0% of
the number of Ordinary Shares issued in the IPO), at an exercise price per share equal to $5.31 (125.0% of the IPO price). The Underwriter&rsquo;s
Warrants and the underlying Ordinary Shares will not be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any
hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the Underwriter&rsquo;s
Warrants by any person for a period of 180 days beginning on the date of commencement of sales of the offering in compliance with FINRA
Rule 5110.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Underwriter&rsquo;s Warrants became exercisable from the date that is six months from the commencement of the sales of the offering,
or March 12, 2023, and will expire four years and six months after such date, or September 12, 2027, in compliance with FINRA Rule 5110(g)(8)(A).
Furthermore, such Underwriter&rsquo;s Warrants shall be exercisable on a cash basis, provided that if a registration statement registering
the ordinary shares underlying the Underwriter&rsquo;s Warrants is not effective, the Underwriter&rsquo;s Warrants may be exercised on
a cashless basis and have anti-dilution terms that are consistent with FINRA Rule 5110(g)(8)(E) and (F).&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Indemnification</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have agreed to indemnify Aegis, its affiliates, and each person controlling Aegis against any losses, claims, damages, judgments, assessments,
costs, and other liabilities, as the same are incurred (including the reasonable fees and expenses of counsel), relating to or arising
out of the IPO undertaken in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Other
Relationships</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aegis
may in the future provide us and our affiliates with such services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
connection with our IPO, we entered into an underwriting agreement with Aegis pursuant to which we paid Aegis an aggregate of $1,275,000
in commissions and non-accountable expenses. In addition, we issued Aegis warrants to purchase five percent (5%) of the Ordinary Shares
issued in the IPO at an exercise price per share equal to 125% of the public offering price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Offer
Restrictions Outside the United States</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
than in the United States, no action has been taken by us or the underwriter that would permit a public offering of the securities offered
by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be
offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with
the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result
in compliance with the applicable rules and regulations of that jurisdiction. Persons who come into possession of this prospectus are
advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus.
This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in
any jurisdiction in which such an offer or a solicitation is unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_010"></A>EXPENSES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Set
forth below is an itemization of the total expenses, incurred and paid in connection with the offer and sale of our securities by us
pursuant to the IPO and including the securities remaining covered by this prospectus.&nbsp;With the exception of the SEC registration
fee and the FINRA filing fee, all amounts are estimates:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">SEC registration fee</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,462.30</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nasdaq listing fee</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">75,000.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">FINRA filing fee</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,193.05</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Transfer agent fees and expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,000.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Directors and officers insurance</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">495,000.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Printer fees and expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,000.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Legal fees and expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">650,000.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounting and professional fees and expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">422,000.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Miscellaneous</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">58,000.00</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,745,655.35</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_011"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certain
legal matters concerning the legality of the issuance of the securities offered by this prospectus and other legal matters concerning
this offering were passed upon for us by Sullivan &amp; Worcester LLP, New York, New York. Certain legal matters with respect to the
legality of the issuance of the securities offered by this prospectus and other legal matters concerning this offering relating to Israeli
law were passed upon for us by Sullivan &amp; Worcester Tel Aviv (Har-Even &amp; Co.), Tel Aviv, Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_012"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
consolidated financial statements as of December 31, 2023 and 2022 and for each of the years in the three-year period ended December
31,2023 incorporated by reference in this prospectus have been incorporated in reliance on the report of Ziv Haft, Certified Public Accountants,
Isr., BDO Member Firm, an independent registered public accounting firm, incorporated herein by reference, given on the authority of
said firm as experts in auditing and accounting. The report on the consolidated financial statements contains an explanatory paragraph
regarding the Company&rsquo;s ability to continue as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_013"></A>ENFORCEABILITY
OF CIVIL LIABILITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are incorporated under the laws of the State of Israel. Service of process upon us and upon our directors and officers and the Israeli
experts named in the registration statement of which this prospectus forms a part, a substantial majority of whom reside outside of the
United States, may be difficult to obtain within the United States. Furthermore, because substantially all of our assets and a substantial
of our directors and officers are located outside of the United States, any judgment obtained in the United States against us or any
of our directors and officers may not be collectible within the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have been informed by our legal counsel in Israel, Sullivan &amp; Worcester Tel Aviv (Har-Even &amp; Co.), that it may be difficult to
assert U.S. securities law claims in original actions instituted in Israel. Israeli courts may refuse to hear a claim based on a violation
of U.S. securities laws because Israel is not the most appropriate forum to bring such a claim. In addition, even if an Israeli court
agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable,
the content of applicable U.S. law must be proved as a fact which can be a time-consuming and costly process. Certain matters of procedure
will also be governed by Israeli law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subject
to specified time limitations and legal procedures, Israeli courts may enforce a U.S. judgment in a civil matter which, subject to certain
exceptions, is non-appealable, including judgments based upon the civil liability provisions of the Securities Act and the Exchange Act
and including a monetary or compensatory judgment in a non-civil matter, provided that among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment is obtained after due process before a
    court of competent jurisdiction, according to the laws of the state in which the judgment is given and the rules of private international
    law currently prevailing in Israel;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment is final and is not subject to any right
    of appeal;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the prevailing law of the foreign state in which the
    judgment was rendered allows for the enforcement of judgments of Israeli courts;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adequate service of process
    has been effected and the defendant has had a reasonable opportunity to be heard and to present his or her evidence;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the liabilities under the
    judgment are enforceable according to the laws of the State of Israel and the judgment and the enforcement of the civil liabilities
    set forth in the judgment is not contrary to the law or public policy in Israel nor likely to impair the security or sovereignty
    of Israel;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment was not obtained
    by fraud and does not conflict with any other valid judgments in the same matter between the same parties;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an action between the same
    parties in the same matter is not pending in any Israeli court at the time the lawsuit is instituted in the foreign court; and&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment is enforceable
    according to the laws of Israel and according to the law of the foreign state in which the relief was granted. </FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
a foreign judgment is enforced by an Israeli court, it generally will be payable in Israeli currency, which can then be converted into
non-Israeli currency and transferred out of Israel. The usual practice in an action before an Israeli court to recover an amount in a
non-Israeli currency is for the Israeli court to issue a judgment for the equivalent amount in Israeli currency at the rate of exchange,
based on the latest official exchange rate published by the Bank of Israel before the payment date. However, the obligated party will
fulfill his duty under the judgment even if they choose to make the payment in the same foreign currency, subject to the laws governing
the foreign currency applicable at that time. Pending collection, the amount of the judgment of an Israeli court stated in Israeli currency
ordinarily will be linked to the Israeli CPI plus interest at the annual statutory rate set by Israeli regulations prevailing at the
time. Judgment creditors must bear the risk of unfavorable exchange rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_014"></A>WHERE
YOU CAN FIND ADDITIONAL INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have filed with the SEC a registration statement on Form&nbsp;F-1 under the Securities Act relating to the IPO. This prospectus does
not contain all of the information contained in the registration statement. The rules and regulations of the SEC allow us to omit certain
information from this prospectus that is included in the registration statement. Statements made in this prospectus concerning the contents
of any contract, agreement or other document are summaries of all material information about the documents summarized, but are not complete
descriptions of all terms of these documents. If we filed any of these documents as an exhibit to the registration statement, you may
read the document itself for a complete description of its terms. The SEC maintains an Internet website that contains reports and other
information regarding issuers that file electronically with the SEC. Our filings with the SEC are also available to the public through
the SEC&rsquo;s website at www.sec.gov.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are subject to the information reporting requirements of the Exchange Act that are applicable to foreign private issuers, and under those
requirements are filing reports with the SEC. Those other reports or other information may be inspected without charge at the locations
described above. As a foreign private issuer, we are exempt from the rules under the Exchange Act related to the furnishing and content
of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery
provisions contained in Section&nbsp;16 of the Exchange Act. In addition, we are not required under the Exchange Act to file annual,
quarterly and current reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are
registered under the Exchange Act. However, we will file with the SEC, within 120&nbsp;days after the end of each fiscal year, or such
applicable time as required by the SEC, an annual report on Form&nbsp;20-F containing financial statements audited by an independent
registered public accounting firm, and will submit to the SEC, on foreign private issuer reports on Form&nbsp;6-K, unaudited six-month
financial information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
maintain a corporate website at <FONT STYLE="background-color: white">www.wearabledevices.co.il</FONT>. Information contained on, or
that can be accessed through, our website does not constitute a part of this prospectus. We have included our website address in this
prospectus solely as an inactive textual reference. We will post on our website any materials required to be so posted on such website
under applicable corporate or securities laws and regulations, including, posting any XBRL interactive financial data required to be
filed with the SEC and any notices of general meetings of our shareholders.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_015"></A>INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
SEC allows us to &ldquo;incorporate by reference&rdquo; information into this prospectus, which means that we can disclose important
information to you by referring you to other documents which we have filed or will file with the SEC.&nbsp;We are incorporating by reference
in this prospectus the documents listed below and all amendments or supplements we may file to such documents, as well as any future
filings we may make with the SEC on Form&nbsp;20-F under the Exchange&nbsp;Act before the time that all of the securities offered by
this prospectus have been sold or de-registered:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
prospectus incorporates by reference the documents listed below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390024023073/ea0200952-20f_wearable.htm">Form&nbsp;20-F</A>
                                            for the fiscal year ended December&nbsp;31, 2023, filed with the SEC on March 15, 2024;&nbsp;and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            description of our securities contained in our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022055087/ea165606-8a12b_wearable.htm">Form&nbsp;8-A</A>
                                            filed with the SEC on September 9, 2022, a<FONT STYLE="background-color: white">s amended
                                            by <A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390024023073/ea020095201ex2-3_wearable.htm">Exhibit
                                            2.3</A> to our 2023 Annual Report, and </FONT>including any other amendments and reports
                                            filed for the purpose of updating such description.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
you read the above documents, you may find inconsistencies in information from one document to another. If you find inconsistencies between
the documents and this prospectus, you should rely on the statements made in the most recent document. All information appearing in this
prospectus is qualified in its entirety by the information and financial statements, including the notes thereto, contained in the documents
incorporated by reference herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
will provide to each person, including any beneficial owner, to whom this prospectus is delivered, a copy of these filings, at no cost,
upon written or oral request to us at the following address: 5 Ha-Tnufa Street, Yokne&rsquo;am Illit, 2066736, Israel, Attention: Chief
Financial Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PART
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>INFORMATION
NOT REQUIRED IN PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item&nbsp;6.
Indemnification of Directors, Officers and Employees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Indemnification</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Israeli Companies Law 5759-2999, or Companies Law, and the Israeli Securities Law, 5728-1968, or the Securities Law, provide that a company
may indemnify an office holder against the following liabilities and expenses incurred for acts performed by him or her as an office
holder, either pursuant to an undertaking made in advance of an event or following an event, provided its articles of association include
a provision authorizing such indemnification:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a financial liability imposed on him or her in favor
    of another person by any judgment concerning an act performed in his or her capacity as an office holder, including a settlement
    or arbitrator&rsquo;s award approved by a court; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable litigation expenses, including attorneys&rsquo;
    fees, expended by the office holder (a) as a result of an investigation or proceeding instituted against him or her by an authority
    authorized to conduct such investigation or proceeding, provided that (1) no indictment (as defined in the Companies Law) was filed
    against such office holder as a result of such investigation or proceeding; and (2) no financial liability as a substitute for the
    criminal proceeding (as defined in the Companies Law) was imposed upon him or her as a result of such investigation or proceeding,
    or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent;
    or (b) in connection with a monetary sanction; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable litigation expenses, including attorneys&rsquo;
    fees, expended by the office holder or imposed on him or her by a court; (1) in proceedings that the company institutes, or that
    another person institutes on the company&rsquo;s behalf, against him or her; (2) in a criminal proceeding of which he or she was
    acquitted; or (3) as a result of a conviction for a crime that does not require proof of criminal intent; and </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses incurred by an office holder in connection
    with an Administrative Procedure under the Securities Law, including reasonable litigation expenses and reasonable attorneys&rsquo;
    fees. An &ldquo;Administrative Procedure&rdquo; is defined as a procedure pursuant to chapters H3 (Monetary Sanction by the Israeli
    Securities Authority), H4 (Administrative Enforcement Procedures of the Administrative Enforcement Committee) or I1 (Arrangement
    to prevent Procedures or Interruption of procedures subject to conditions) to the Securities Law. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Companies Law also permits a company to undertake in advance to indemnify an office holder, provided that if such indemnification relates
to financial liability imposed on him or her, as described above, then the undertaking should be limited and shall detail the following
foreseen events and amount or criterion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; &nbsp; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to events that in the opinion of the board of directors
    can be foreseen based on the company&rsquo;s activities at the time that the undertaking to indemnify is made; and &nbsp; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; &nbsp; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in amount or criterion determined by the board of directors,
    at the time of the giving of such undertaking to indemnify, to be reasonable under the circumstances. &nbsp; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have entered into indemnification agreements with all of our directors and with all members of our senior management. Each such indemnification
agreement shall provide the office holder with indemnification permitted under applicable law and up to a certain amount, and to the
extent that these liabilities are not covered by directors and officers insurance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Exculpation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
the Companies Law, an Israeli company may not exculpate an office holder from liability for a breach of his or her duty of loyalty, but
may exculpate in advance an office holder from his or her liability to the company, in whole or in part, for damages caused to the company
as a result of a breach of his or her duty of care (other than in relation to distributions), but only if a provision authorizing such
exculpation is included in its articles of association. Our amended and restated articles of association provide that we may exculpate,
in whole or in part, any office holder from liability to us for damages caused to the company as a result of a breach of his or her duty
of care, but prohibit an exculpation, in advance, from liability arising from a company&rsquo;s transaction in which our controlling
shareholder or office holder has a personal interest. Subject to the aforesaid limitations, under the indemnification agreements, we
exculpate and release our office holders from any and all liability to us related to any breach by them of their duty of care to us to
the fullest extent permitted by law.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 25; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Limitations</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">The
Companies Law provides that the Company may not exculpate or indemnify an office holder nor enter into an insurance contract that would
provide coverage for any liability incurred as a result of any of the following: (1) a breach by the office holder of his or her duty
of loyalty unless (in the case of indemnity or insurance only, but not exculpation) the office holder acted in good faith and had a reasonable
basis to believe that the act would not prejudice us; (2) a breach by the office holder of his or her duty of care if the breach was
carried out intentionally or recklessly (as opposed to merely negligently); (3) any act or omission committed with the intent to derive
an illegal personal benefit; or (4) any fine, monetary sanction, penalty or forfeit levied against the office holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Under
the Companies Law, exculpation, indemnification and insurance of office holders in a public company must be approved by the compensation
committee and the board of directors and, with respect to certain office holders or under certain circumstances, also by the shareholders.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
amended and restated articles of association permit us to exculpate (subject to the aforesaid limitation), indemnify and insure our office
holders to the fullest extent permitted or to be permitted by the Companies Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item&nbsp;7.
Recent Sales of Unregistered Securities </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Set
forth below are the sales of all securities by the Company since March 2021, which were not registered under the Securities Act. The
Company believes that each of such issuances was exempt from registration under the Securities Act in reliance on Section 4(a)(2) of
the Securities Act, Rule 701 and/or Regulation S under the Securities Act.&nbsp; The conversions described below were exempt from registration
under Securities Act in reliance on Section 3(a)(9) of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
April 2021, the Company converted all of the above convertible securities into an aggregate of 3,081,102 ordinary shares, NIS 0.01 par
value per share, or the Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
April 2021, we issued to a group of investors 1,343,374 Ordinary Shares and warrants to purchase 671,687 Ordinary Shares, at an exercise
price of 125% of the per share purchase price in an initial public offering, for a total consideration of $3.025 million. Prior to the
issuance, (i) we converted each one of our issued and outstanding ordinary A shares into one Ordinary Share; (ii) reclassified our authorized
share capital of 2,000,000 ordinary A shares into 2,000,000 Ordinary Shares; (iii) increased our authorized share capital by 10,000,000
Ordinary Shares; and (iv) increased the number of Ordinary Shares under our 2015 Share Option Plan, or the 2015 Plan, by an additional
200,000 Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
November 2021, we issued warrants to purchase up to 22,205 Ordinary Shares, issued to a consultant, at an exercise price of $2.25 per
share to a consultant, which all are vested as of March 25, 2024. In September 2022, we issued warrants to purchase up to 23,640 Ordinary
Shares, issued to an advisor, at an exercise price of $4.23 per Ordinary Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
January 2022, we began entering into certain simple agreements for future equity, or the SAFEs, for aggregate proceeds of up to $3 million,
of which we received $500 thousand under the SAFEs. Any amounts received under the SAFEs we enter into will be automatically converted
into our Ordinary Shares in the event we close an Equity Financing (as defined hereinafter) at a discount of 20% from the per share purchase
price in such Equity Financing. An Equity Financing is a transaction or series of transactions with the principal purpose of raising
capital in an aggregate amount of at least $5,000,000, excluding all outstanding (i) SAFEs, and (ii) other convertible securities (if
any), pursuant to which we issue and sell Ordinary Shares at a fixed pre-money valuation. In addition, we agreed to issue to each SAFE
investor a warrant to purchase our Ordinary Shares with an exercise price equal to 150% of the public offering price in such offering
for an aggregate amount of up to 25% of such investor&rsquo;s SAFE amount. The warrants shall be exercisable until the earlier of: (i)
eighteen (18) months from January 2022; or (ii) in a change of control event, which generally covers (a) transaction in which any person
or group becomes the beneficial owner, directly or indirectly, of more than 50% of our outstanding voting securities with the right to
vote for the election of members of our board of directors, or (b) any reorganization, merger or our consolidation, or (c) a sale, lease
or other disposition of all or substantially all of our assets. Following the consummation of our initial public offering, or IPO, in
September 2022, $100 thousand received under the SAFEs were repaid in cash and $400 thousand were converted into 118,204 Ordinary Shares,
based on the IPO price of $4.23 per Ordinary Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
February 2023, we issued a total of 169,125 Ordinary Shares to Alpha Capital Anstalt, or Alpha, and certain other investors pursuant
to the terms of their April 2021 share purchase agreements with us, as amended by the June 2022 written consent with Alpha.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Since
March 2021, we have granted to our directors, consultants and service providers, officers, and employees options to purchase an aggregate
of 1,089,385 Ordinary Shares under our 2015 Plan, with an exercise prices ranging between $0.003 and $2.251 per share. As of March 25,
2024, 372,771 options granted to directors, officers and employees were exercised, and 133,163 options forfeited, such that the total
outstanding amount of options allocated or granted to directors, officers and employees as of March 25, 2024 is 1,749,189.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item&nbsp;8.
Exhibits and Financial Statement Schedules </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibits:</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: top; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
    Number</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 90%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit&nbsp;Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1 </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022058006/ea165832ex1-1_wearable.htm">Form
    of Underwriting Agreement by and among Wearable Devices Ltd. and the underwriters named therein (filed as Exhibit 1.1 to Form 6-K
    (File No. 001-41502) filed on September 22, 2022 and incorporated herein by reference).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1 </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022012239/ea156798ex3-2_wearable.htm">Amended
    and Restated Articles of Association of Wearable Devices Ltd. (filed as Exhibit 3.2 to Form F-1 (File No. 333-262838) filed on September
    8, 2022 and incorporated herein by reference).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022018390/ea157448ex4-1_wearable.htm">Form
    of Representative&rsquo;s Warrant. (filed as Exhibit 4.1 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated
    herein by reference ).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022019279/ea158314ex4-3_wearable.htm">Form
    of Warrant Agent Agreement (filed as Exhibit 4.3 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein
    by reference ).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3 </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022058006/ea165832ex4-1_wearable.htm">Form
    of Warrant (filed as Exhibit 4.1 to Form 6-K (File No. 001-41502) filed on September 22, 2022 and incorporated herein by reference).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022018390/ea157448ex5-1_wearable.htm">Opinion
    of Sullivan &amp; Worcester Tel Aviv (Har-Even &amp; Co.), Israeli counsel to Wearable Devices Ltd.</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022018390/ea157448ex5-2_wearable.htm">Opinion
    of Sullivan &amp; Worcester LLP, U.S counsel to Wearable Devices Ltd.</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022012239/ea156798ex10-1_wearable.htm">Form
    of Indemnification Agreement (filed as Exhibit 10.1 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated
    herein by reference).</A>&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2 </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022008340/ea155863ex10-2_wearable.htm">Wearable
    Devices Ltd. 2015 Share Option Plan (filed as Exhibit 10.2 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated
    herein by reference ).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390023072128/ea184450ex10-1_wearable.htm">First
    Amendment to Wearable Devices Ltd. 2015 Share Option Plan (filed as Exhibit 10.1 to Form 6-K (File No. 001-41502) filed on August
    31, 2023 and incorporated herein by reference)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022018390/ea157448ex10-3_wearable.htm">Share
    Purchase Agreement, dated April 22, 2021, by and between Wearable Devices Ltd. and Alpha Capital Anstalt (filed as Exhibit 10.3 to
    Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</A>&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5#</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022018390/ea157448ex10-4_wearable.htm">Agreement,
    dated July 16, 2020, by and between Wearable Devices Ltd. and the Israeli Innovation Authority (filed as Exhibit 10.4 to Form F-1
    (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022012239/ea156798ex10-5_wearable.htm">Compensation
    Policy (filed as Exhibit 10.5 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022040341/ea163052ex10-6_wearabledev.htm">Senior
    Credit Facility Agreement, dated July 4, 2022, by and between Wearable Devices Ltd. and L.I.A. Pure Capital Ltd. (filed as Exhibit
    10.6 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022040341/ea163052ex10-8_wearabledev.htm">First
    Addendum to Senior Agreement, dated July 19, 2022, by and between Wearable Devices Ltd. and L.I.A. Pure Capital Ltd. (filed as Exhibit
    10.8 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022008340/ea155863ex21-1_wearable.htm">Subsidiaries
    of Wearable Devices Ltd. (filed as Exhibit 21.1 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein
    by reference).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1**</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea020267901ex23-1_wearable.htm">Consent of
    Ziv Haft, Certified Public Accountants, Isr., BDO member firm, an independent registered public accounting firm.</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2* </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022018390/ea157448ex5-1_wearable.htm">Consent
    of Sullivan &amp; Worcester Tel Aviv (Har-Even &amp; Co.) (included in Exhibit 5.1)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3* </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022018390/ea157448ex5-2_wearable.htm">Consent
    of Sullivan &amp; Worcester LLP (included in Exhibit 5.2)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1* </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022008340/ea155863-f1_wearabledev.htm#power_001">Power
    of Attorney</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107* </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1887673/000121390022054088/ea164883ex-fee_wearabledev.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Fee Table</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Financial
Statement Schedules:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
financial statement schedules have been omitted because either they are not required, are not applicable or the information required
therein is otherwise set forth in the Company&rsquo;s financial statements and related notes thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item&nbsp;9.
Undertakings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)
The undersigned Registrant hereby undertakes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            file, during any period in which offers or sales are being made, a post-effective amendment
                                            to this registration statement:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            include any prospectus required by section 10(a)(3) of the Securities Act of 1933;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            reflect in the prospectus any facts or events arising after the effective date of the registration
                                            statement (or the most recent post-effective amendment thereof) which, individually or in
                                            the aggregate, represent a fundamental change in the information set forth in the registration
                                            statement. Notwithstanding the foregoing, any increase or decrease in volume of securities
                                            offered (if the total dollar value of securities offered would not exceed that which was
                                            registered) and any deviation from the low or high end of the estimated maximum offering
                                            range may be reflected in the form of prospectus filed with the Commission pursuant to Rule
                                            424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change
                                            in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration
                                            Fee&rdquo; table in the effective registration statement;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            include any material information with respect to the plan of distribution not previously
                                            disclosed in the registration statement or any material change to such information in the
                                            registration statement.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
                                            for the purpose of determining any liability under the Securities Act of 1933, each such
                                            post-effective amendment shall be deemed to be a new registration statement relating to the
                                            securities offered therein, and the offering of such securities at that time shall be deemed
                                            to be the initial bona fide offering thereof.</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            remove from registration by means of a post-effective amendment any of the securities being
                                            registered which remain unsold at the termination of the offering.</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            file a post-effective amendment to the registration statement to include any financial statements
                                            required by Item 8.A. of Form 20-F at the start of any delayed offering or throughout a continuous
                                            offering. Financial statements and information otherwise required by Section 10(a)(3) of
                                            the Act need not be furnished, provided that the registrant includes in the prospectus, by
                                            means of a post-effective amendment, financial statements required pursuant to this paragraph
                                            (a)(4) and other information necessary to ensure that all other information in the prospectus
                                            is at least as current as the date of those financial statements. Notwithstanding the foregoing,
                                            with respect to registration statements on Form F-3, a post-effective amendment need not
                                            be filed to include financial statements and information required by Section 10(a)(3) of
                                            the Act or Item 8.A of Form 20-F if such financial statements and information are contained
                                            in periodic reports filed with or furnished to the Commission by the registrant pursuant
                                            to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated
                                            by reference in the Form F-3.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
                                            for the purpose of determining liability under the Securities Act of 1933 to any purchaser:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the registrant is relying on Rule 430B:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part
                                            of the registration statement as of the date the filed prospectus was deemed part of and
                                            included in the registration statement; and</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of
                                            a registration statement in reliance on Rule 430B relating to an offering made pursuant to
                                            Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by
                                            section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in
                                            the registration statement as of the earlier of the date such form of prospectus is first
                                            used after effectiveness of the date of the first contract or sale of securities in the offering
                                            described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer
                                            and any person that is at that date and underwriter, such date shall be deemed to be a new
                                            effective date of the registration statement relating to the securities in the registration
                                            statement to which that prospectus relates, and the offering of such securities at that time
                                            shall be deemed to be the initial bona fide offering thereof. <I>Provided, however</I>, that
                                            no statement made in a registration statement or prospectus that is part of the registration
                                            statement or made in a document incorporated or deemed incorporated by reference into the
                                            registration statement or prospectus that is part of the registration statement will, as
                                            to a purchaser with a time of contract sale prior to such effective date, supersede or modify
                                            any statement that was made in the registration statement or prospectus that was part of
                                            the registration statement or made in any such document immediately prior to such effective
                                            date; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as
                                            part of a registration statement relating to an offering, other than registration statements
                                            relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be
                                            deemed to be part of and included in the registration statement as of the date it is first
                                            used after effectiveness. <I>Provided, however</I>, that no statement made in a registration
                                            statement or prospectus that is part of the registration statement or made in a document
                                            incorporated or deemed incorporated by reference into the registration statement or prospectus
                                            that is part of the registration statement will, as to a purchaser with a time of contract
                                            of sale prior to such first use, supersede or modify any statement that was made in the registration
                                            statement or prospectus that was part of the registration statement or made in any such document
                                            immediately prior to such date of first use.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
                                            for the purpose of determining liability of the registrant under the Securities Act of 1933
                                            to any purchaser in the initial distribution of the securities, the undersigned registrant
                                            undertakes that in a primary offering of securities of the undersigned registrant pursuant
                                            to this registration statement, regardless of the underwriting method used to sell the securities
                                            to the purchaser, if the securities are offered or sold to such purchaser by means of any
                                            of the following communications, the undersigned registrant will be a seller to the purchaser
                                            and will be considered to offer or sell securities to such purchaser:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            preliminary prospectus or prospectus of the undersigned registrant relating to the offering
                                            required to be filed pursuant to Rule 424;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            free writing prospectus relating to the offering prepared by or on behalf of the undersigned
                                            registrant or used or referred to by the undersigned registrant;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            portion of any other free writing prospectus relating to the offering containing material
                                            information about the undersigned registrant or its securities provided by or on behalf of
                                            the undersigned registrant; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            other communication that is an offer in the offering made by the undersigned registrant to
                                            the purchaser.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
                                            as indemnification for liabilities arising under the Securities Act of 1933 may be permitted
                                            to directors, officers and controlling persons of the registrant pursuant to the foregoing
                                            provisions, or otherwise, the registrant has been advised that in the opinion of the Securities
                                            and Exchange Commission such indemnification is against public policy as expressed in the
                                            Act and is, therefore, unenforceable. In the event that a claim for indemnification against
                                            such liabilities (other than the payment by the registrant of expenses incurred or paid by
                                            a director, officer or controlling person of the registrant in the successful defense of
                                            any action, suit or proceeding) is asserted by such director, officer or controlling person
                                            in connection with the securities being registered, the registrant will, unless in the opinion
                                            of its counsel the matter has been settled by controlling precedent, submit to a court of
                                            appropriate jurisdiction the question whether such indemnification by it is against public
                                            policy as expressed in the Act and will be governed by the final adjudication of such issue.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            undersigned registrant hereby undertakes that:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
                                            for purposes of determining any liability under the Securities Act of 1933, the information
                                            omitted from the form of prospectus filed as part of this registration statement in reliance
                                            upon Rule&nbsp;430A and contained in a form of prospectus filed by the registrant pursuant
                                            to Rule&nbsp;424(b)(1) or (4), or 497(h) under the Securities Act shall be deemed to be part
                                            of this registration statement as of the time it was declared effective.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
                                            for the purpose of determining any liability under the Securities Act of 1933, each post-effective
                                            amendment that contains a form of prospectus shall be deemed to be a new registration statement
                                            relating to the securities offered therein, and the offering of such securities at that time
                                            shall be deemed to be the initial&nbsp;bona fide&nbsp;offering thereof.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Act of&nbsp;1933, the registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form F-1 and has duly caused this registration statement on Form F-1 to be signed on its behalf
by the undersigned, thereunto duly authorized, in Yokne&rsquo;am Illit, Israel, on March 27, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WEARABLE DEVICES LTD.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 36%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Asher Dahan</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher Dahan </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Act of 1933, this amendment to the registration statement on Form F-1 has been signed by the following
persons in the capacities and on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature </B>&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B>&nbsp;</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 22%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B>&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;/s/ Asher Dahan</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer, Chairman of Board of Directors&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 27, 2024</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher Dahan &nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;/s/ Alon Mualem</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 27, 2024</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon Mualem&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial and Accounting Officer)&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 27, 2024</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eli Bachar &nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 27, 2024</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yaacov Goldman&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 27, 2024</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ilana Lurie &nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 27, 2024</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guy Wagner&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*By:</FONT></TD>
    <TD STYLE="width: 30%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;/s/ Asher Dahan</FONT></TD>
    <TD STYLE="width: 40%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;March 27, 2024</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher Dahan</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attorney-in-fact</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SIGNATURE
OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the Securities Act of 1933, as amended, the undersigned, Mudra Wearable, Inc., the duly authorized representative in the United States
of Wearable Devices Ltd., has signed this registration statement on March 27, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mudra Wearable, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;/s/ Asher Dahan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Asher Dahan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:&nbsp;&nbsp;&nbsp;President, Director</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">II-7</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ea020267901ex23-1_wearable.htm
<DESCRIPTION>CONSENT OF ZIV HAFT, CERTIFIED PUBLIC ACCOUNTANTS, ISR., BDO MEMBER FIRM, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-indent: 20pt; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ex23-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center; text-indent: 0in; color: fuchsia"><FONT STYLE="color: Black"><U>Consent
of Independent Registered Public Accounting Firm</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; color: fuchsia"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black">Wearable
Devices Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black">We
hereby consent to the incorporation by reference in this Post- Effective Amendment No. 4 to the Registration Statement on form F-1 of
Wearable Devices Ltd. (&quot;the Company&quot;) of our report dated March 13, 2024, relating to the consolidated financial statements
which appears in Wearable Devices Ltd.&rsquo;s Annual Report on Form 20-F for the year ended December 31, 2023. Our report contains an
explanatory paragraph regarding the Company&rsquo;s ability to continue as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black">We
also consent to the reference to us under the caption &ldquo;Experts&rdquo; in such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black">/s/
Ziv Haft</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; color: fuchsia"><FONT STYLE="color: Black">Ziv Haft</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; color: fuchsia"><FONT STYLE="color: Black">Certified
Public Accountants (Isr.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; color: fuchsia"><FONT STYLE="color: Black">BDO Member
Firm</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.95pt 0 0; text-align: left; color: fuchsia"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.95pt 0 0; text-align: left; color: fuchsia"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; color: fuchsia"><FONT STYLE="color: Black">March 27,
2024&#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black">Tel Aviv,
Israel</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; color: fuchsia"><FONT STYLE="color: Black"><IMG SRC="image_002.jpg" ALT="">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !% ',# 2(  A$! Q$!_\0
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M4 LQ!_$UE0VSK?VO]C:=J-@!,#<+*=EN(_XAL)()]-HZ]\4 =C1110 4444
C%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex23-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  T '$# 2(  A$! Q$!_\0
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MTT\IQ'"FW&YF/T]R?3U=3DA7IN5E+K]P1YG2FE=KH6_A ?\ BA^JL?M4O*C
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MSJAPQ7. ?QKC6^%=HV[.JW'/)^1>O//ZG_.<]'X<\-1^'8+B.*YDF\]]Y9P
M0<41E4<O>1EB*6!C3_<3;EV:LC?HHHK4\T6BBB@ HHHH **** "BBB@ HHHH
/ **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !N R # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHJ&20*ZK\Y9@2 G/ /)/&!UR,D;@&VY*D4FTM6[(/O\ DKDU%0+*N_8=ZL<X
M\P$9QC.,@9Z@9&03D G%*MQ"S^6K@OC<4_B"\<L/X?O*,'!R1Q0VDF[Z+=^@
M?UV)J*C\U<D888.TDJ<!LXQGN3QTSUP<'(I&GC4D,V,=200.F3SZ!068]%56
M9B%!-"DI;.X$M%,219 2N<#H2" 1V*YZ@]0>XY'!I], HHJI/,L9()8$@@%2
M>#LR,<XSP".!R2,YI-V5WLE*3>]E&$IMVW>D7HM1-V3?KUMT;W>B^%_<6Z*\
M/^ 7QIT/X[>$-=\6^'M,US2K#1/'_C;X?RP^(#:F\N=1\#:W/H6I7\(M+J\C
M2PN[RWE>S1Y1,(0#*B,<5[A44JM.O2IUJ,N>E5A&<)6<;QDM/=EJG=--/JGY
M'7C<#CLLQ>(R_,L+4P6/PE3V.+PE5Q=3#5U"E.5*;C[KE&-:DVXZ>^K!12,P
M4%B0 .I)  ]R3@ >Y--$@..&!]&4@C) '!Y.<]1E1ALD8K0Y1]%%% !12$@#
M)X J-9HW8JK98$!E[J2,C<O5<C!4L &4AER.: ):*"< GTYI 0>G;V- "T45
M'+G9D$@@J>"1D!@2"000#T)]#1Z*_E]P:==%Z7_!:L=O7.-PSP,?7I3J^?O!
M'QJT3QI\8OB]\(K'3=9M-:^$"_#Z?7-2OC;'2-23Q_IFHZMI:Z3Y=T]S&8;?
M2KI+F.XM( TLD!1G558_0-13JTZL92IR4XQJUJ+:_GHS4)KY2;7?1WL=.+P.
M.RZM'#9CA9X/$3PN QT:-24)N6#S3!4,RR[$1G3;A*&+R_%87%T[.ZIXB$9>
M\I!1115G,%%1/,B-M;.3C 52Q.<]%7+$=,G;M!(&<G%1M<Q;@,DD[1@!\@L
M5! &02"#A@" 1D#(S*E%OE33:OIZ;A9O97?9%FBH/.B!VLQ!.,<L>O0<=SD
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M8G P%W$G)Q\JCEL$J&(!V[E+$#D#:2NW9;?>&O17):*B65&) W9 S@@YP.>
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M-%Z>]HW:UTFU>]M"*>)C2ISC+#QG.4W*+M%**Y9Q2?NZKWD^5M+3NS\&H?\
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MI?>H03[J$?Y5;]+\-O\ D0>-O=^#^/B]]5_Q$3PDT>NJT6FSLK['Z=@8  Z
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M!7Y:[?AKU7S[I'X&>,/^"GO[;4 ^)/C6UT[X0?#S1/@KX!_8!^('CGX4^,O
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MZ7PW;:-\/8(_":>)OC!>_#'0_#OCNW\-:MKMCH/A?QWJDMCXC\1:SH/]KO\
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MBOP9H<T6HSQZ8FB>+[[2[_68KO30&@O)IY]'L&AGD(>U\IU0%974^NVJ;$(
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M9[J=W3J0I&,<8ZU^9'P@D9_^"IO[63;/]9^SY^S]D9YC4/X@(8^H8J@& /\
M6#TY_3FY21T B"[E)(W' R%.WL?XL=N!^5>%:%\$/!OA7XV^./CW8PWJ>//B
M)X8\*^#O$MS)JMS/IIT+P<]Z^BV]II1 M;2=7OG\ZY7=)*L:*XR1CCS#!5<5
M6RJM2E3_ -@S*&.JQJ2<6Z4<)C,'R4TE[U2/UVI62;2:C9MVBCZ_A'B7 9!E
MOB+@<=2QDZO%O .*X9RZ>&I*I3I9A7XLX%SBG4Q,G)<E"-#AS&>TDE)I5(M+
M1->]LNY67^\".QZ^QR*^2OB)\*/B;XW\7?%33_$GBM;_ ."/C?X-7G@B?P;H
M6C6]GXDO;C4E\;VNHV.B:EJGBQ]'TW7UT_5M+>+Q+J6BFPU(_9M*O[5;>Q,H
M^M@<@'IFD*J>JJ>".0#P>2.G0D D>U=\X1FK2O;R;7Y'QJ=NWS2?YGY<^$?V
M=OC=K'@_XC:3XVAMK>3]H?XD^!M'^(+ZA_PKW1?%/@GX!^"_A_IOA'7X;J'X
M71MX0E^('Q'T3PZO@NTTWP5>:G;^"[#QG:ZK;>);O_A%["$>N:M\-OB9XF^.
M<5W9^ ;7X9^"_A5X4\6>'?@+XXT4?#W6K&W\4^+_  9INAZA\0_$?A8>(M+U
MQ=.T335E\&>%/ATFD2Z9>1VFI>(O$M["\OANTT;[J*(0 44@< %1@#&, 8XX
MX^G%&U?[J^O0=>.>GL/R'I6;H145&%XVOJY.3?JY7;U_K0N56<FVVKO^Y%+I
MLK62T_%GQ\?A1\0]5^*7@KQ5X^ETGQCHGP2^'=WJ?A/4+73= \/ZM\1OCCXL
MMM=T'7_$]_HD-S)I7AA?!'@&)?#?A&.74DL;N[^)_BNYN+F.VT;3KFO/O@1\
M)/CCIGB#X@>++J]UOX1Z1XO^,VC^-]1T3Q_I7PK^(/Q*\=>&-/\ !G@CPUJ'
MA_Q1K?PYUNY\%^$K#3;WPY?67@2\\+WE[K=EX;N+6;6K1=8MI8W_ $"V)G.U
M<\<[1GC..<=MS8],G'4TGEH 0$0 G)&T8)V[<GCD[?ER?X>.E4J,+*ZNTE=W
M>]M?O] 52:36EF[M.,7UOU6FO16738_.#QU^S1X\^(?[.G[75GK/ACPI=?'+
M]HK2?&&FZ1HUS<:/+HOAK0_#=IJOA?X%^%(=::VFL(4\.Z2\WBR_U*%56R\<
M>,O%UWISV[O$MM+\;_V:/C-XW_:4^"?QRTW6?!'BC1?AM\6H]7T_1-5T[5-(
MUWX>?#&;X"?%GPAXGTCPY?KXM?1-5USQOX\\8Z7<:MJJZ1IU[<"W\(/J,\^C
M_#Z*'4OT:\N/.=B9]=JYXY'.,\'FAT5AC8K9X((&,<G';C/;I5."<'!:)JV[
M75/??YCC5G"2FN5M.]G%6VMY6T_(_,KP?\-_C1X4^#'Q(\%VW@GX^6W@34Y?
M#7A/X.?#Z+XA_L_ZI\=_AOH$.@7.A>(+M/B!K'BV[\"GP:]Z+!?"EMJ'BKQ1
M\0/#FBOJCV]U88T3PUX?\B;]DKXX7&@>'/AB/"FB^'Y-=O?V3?&,_P 6_"FN
M>'+70OA"O[/GPJT+PAXC^&>BZ1%J-MX_NK;4-4\-:B?!DNAZ+X@T;[/\4O&$
MFKZQI^G6<=MJG['"%.08D 8[FP!RPZ,>N3TY()I?(B!R$7(.1\J]< =<=P /
MH .@K#ZM'K4FG9V45S1U[OE=M=/);,TEC*U]*5*V]]VOEU>E^S>Z5SX8_90^
M%_Q \*>)-=\6>,OAKI_PBLXO@?\  #X*V'@^SUSP[K,>HZI\&1\11K7C/3!X
M5U;5M*MO"VJ6_C73=&\*G5#8^*;C1] A?6]'TDR6]FOVY<DX4@9*MC'3/R''
M/O@U<VYZH#TSG9V((S\O8@'\.*@>)R!N )^4J<G 9%.2>#QCH#D'H0,<ZJG+
ME<7)7Y9.F]&H2<)0UT5TXS:LUYK4Y*D_:WDX.ZY)6MR\W+5I2<5;6[2;]$?G
M%^P)\VN_MR(.J_ML_%5L#G(.D>%^ >/^>9YP<]A7Z11 F$*1C&Y>>00&.&XQ
MP1@XSWZFO%_A#\&?!'PDN_B1>^#+;4;:Y^*7Q$U?XF>+UU+69]5$_BK6[:V@
MU*XL4N-K:?:RQVEN$LH@T<7EGG<S$>VIN"X8 $9  ] >/QQC/]>M<V6X>KA,
M#AL-54%.BJT6H2YHN#KUZE)W>O-RU4Y+I)M=$?8<?9_@N*>+LTS[+Z>(I8/'
M4LFA1AB::IUH_P!F<+<*Y%7C4BG)13Q618F="5VZE"I2G*S;2^6_B!\,_B5X
MR^(FLQ:CXMB/P3\2_"+QCX%U_P *:=ILMEKUQ/XHDL[.>'3=87Q7916>L2Z?
M]NDL/$[:)C2I)X=/C@\N6:ZC^1? /[-G[0,?@?XG6NIWFHZ+=_%2Q^"_P2T>
MT\4WOPPL?$'PU^ 7@.VU72?%?C.]TWX2V\WA"7XJW/@[Q3XE\(>&YM!\2^(K
MZ(VGA;4YO$.GZ=:P^&M%_5QT#')4$XQGCIDG'()QS].:C*J@)*  G!/R'KG)
M.5Z$$Y/?)SUKIJ454<9.;YH?"MHJ^CO;26C=KIV?=I6^45:<;)4XV5O?O>6F
MJ]UZ:O>^Z7:]_A?5_A1X[UKXR>"M)TGP!:?#CX5? W0M0_X4KXQ\.GP)JT47
MC[4OA1K?PZL/$_B'PXWB#3O$)\+?#[POJS>&/#'@R+1[J;Q'?37&L:[J.DZ/
MI.BZ:>SG^$_Q$\2_$KX0R_$C5=,\8^$OA!X?OO&-UXGCTG0O#ES\0OC1JM[J
MV@^%[R[\*:?<7_\ 8FC_  P\)76NZG9*MW<VFJ^(_%.E:E9I)J/A@"OKA50Y
M^5,$<\(<C.1G Y&>>>,\]:5HXL9,:'''**>#N!'([^8^?9V_O'-0I\L7!V=[
MWLUJFDNEK?UJ3[1R?M/A:5KVMM=WMKKJ]5]W0^-?AW\&?BM97GB'XE7WB?0O
MAQ\0_B)\3(O%/Q T^R\+Z%XVM1\+_",DFC?#CX2VFI37UG#H\>C^%X[K5M8U
MK2/MCMXR\:>-M3L%8ZA#./F-_@1\<8U^V^&_!GQ%M?AO\-_C=\&_BMX7^"?Q
M(\??"CQ-XX\4W7@[Q#\1I_B;'X*\1Z+XJO?"^C^&M:M=>\(>)/!?ACXE>.((
MH?%'A^YNK8?#F7[/!)^LP"(&"(%W9<[5 !9NK-CJ3_$3DG'-, 4_P+U!Y$?4
M$,#]WJ" <]00#UQ4SHN?+;11NEK;=I^=UHO^&#VKC=VOS6;=D_3JFM^Q^5/A
M#X#?&_PGXP^%FK^#/"7B+P'XTN_%.NZO\0/%DOBWX7^(?@EH_P (->^,'Q1^
M*@^".I>#7UE_'&N^)_!EC\0)M%\!ZMX+\/:#IFE:O(E_)X^?P_8W6CZI;A_9
M7^+7@W3/B'K%W<P>-O&%UK_P>^(WAKQ9\/-*\(V7CKQO\7_#WBKQW=>(?%WB
MS3OC7XUOO +Z+:VGC39%HUPVGS>&O#D%AIWPX6UU;P9X.TU/U*$*=HEZ ?P?
M='('3[HP"!T&!@<"G&-2 &C5@I)&0C8+ ACROWB"0QZD$Y)R:Q^J[?O9KI[N
MK\]U;Y^2-OKE9[TZ<=M5&,F[.Z6UTEVVU?5Z?CUX6_9.^.7@6UTWP=<^#/"_
MBZ\\>:K\!O&>M?%JQUSPYH^B_"+Q!\._VH?B'^T7XTTX^'X9?#FHW_V4^-FM
M?AM/\._!L.EZCK[7:^(M,\.Z&IFE][_8I^$7Q8^$:?\ ",>)M!\5>%/!.@?"
M_P (>'=6TKQ9\0?"WQ /BSXUPZMXEU+QQ\3/!EUX=U"_O=&\/>*[74K6XUJ#
MQ!;>&;_7_$5W#K/_  A6G:K%KNO>(_T*,8/5 ?;*X'.>FW )."<#KW)%*D:+
MNQ&H)&"<*21R2"0,GDDG.<DGU-:4Z"IR4E-NR:L[]5]U^OX;:"GB:M5.$H04
M9--R22>EK:+:]ME9)ZI7;8VXSLX&<'=CI]T9Q^/Z>E?FYKQQ_P %6OAJN#N'
M[%'C13TXQ\8+(@GTSCBOTCN Q3Y<8&=WLN.<>_\ GI7B)^"OA:]^.VC?M 7<
M-U)X^T3X>:M\+;&Z74[E=/'A'5_$-OXGN4GTH?Z--J"ZE:1+#=-^\B@DE0$@
M\Y8W"U,4L)[-TE]5QM#$U/:2<7*G3G>2I))\\[/1.RNK7/H^$,_PG#V*XFGC
M:>)J1SK@'C+AO"?5J2J1AF&>8+)\+A)XAN4?9T?]FK\TES64&^6Z1[>PSM .
M,JHSS_0@_J*^0OBY\*_V@?%7QO\ @OXR\#_%'0_#_@'P7K'BC4-?\.W7@VUU
M&ZM;>^\ ZCH2EIQXCTY_$B:MJ]S&D-O)9V@\.23)J*?V@]M L?U^5.5]@,_@
M:?M4]54_@/\ /8?E77-*4;/MT;OIML?,0DZ;C.-N91M[R4E:UFG&2:UU7HS\
ML?!'[.GQF\%?$/QAXO\ !FFZW/X/^&GA']H'3O@;X+^)?B3X<A/%WQ ^,WQ#
MLO'EWJ'B+6/!;:UK.I_#73?$FFW.OZ1/XZUVU\5V::S#;1^$--U/PZNIZUVV
MO_ 'QAHWA_X)? S1/A\_BKX7:/K/A;Q_\9_B98:KX(T_Q;XM\<Z%\2+/XE7U
ME#9:OK^@WVDP^*?B3:I\0/&OB&Q35M0;2)=0\-^'[&'6]6DUFQ_13R8_[H_A
M/1>JD%3T_A(!7T(&,8%.$:  !%&  /E'09 [=MS?]]-ZFN98=+X:DY=^>/+:
MUK6T[K;MIYO26)JU-)1A!+;EL[Z-:Z;ZMWZR=WT2_*']J7]G7]HWQS'9):ZK
MJ?QCU>?X<_&KP1IVO^%K/X8?#"VMI?B+>?#^^TCP+\7="\6ZZUKKOP)U"7P:
M\WC2\\!?\7;DEMFM=*GM(+@O+Z'\>O@1\>/%&AV%WHWBJ3Q_\3;A?B9X)\,Z
MBO@KX/:+\/\ P1\.OBUHFC6OB;0OB+HWC636;GQ#X=M;CPKH@M]>\)^'=8\=
M7@MYM*N_#%QH6JZPT'Z,E%!SL48Q@X0<G:./E)'1>_\ "/04FU23\A/4$J%(
M.<'G ZGC/'89IO#N33E4DM+7AJ].B7YO6PHXJI%KEIQ;C>W-",8]F[^?96O^
M?P9#^SQ\4;[4=0.D>*-*\&7/PQ^"?A_X)? 3QW+:1>(+XZAK&D^'XOBO\6]6
MT&VU*VN;'Q%?VWAK0?!GA);K79=2T2'3=?U0%8=>N;*Y^>T_8B^-:_!WQ5\,
MK:]^$%CH&C_$CXS^+OA]\.4\/>([SPYJ^I>*-2@3P#XT\1:I/XZ:X?6]!L)=
M?UNUT;6QJMHOC37+/QAKLFK^)M#TR_M?UX2*- =B*H8Y(VJ,GID@ <D=SVQ3
M]B9W;5W8 SM&<#=@9QG WM@=MS?WCDAA^2?-&<FKZ\S:;Z.\;66R2\DBUBJ^
M_N1?;DA*S5TM6F_M-^K?E;Y1\._!_6;/]J+Q[\6M5T7PXWA7QK^SC\+OAUJ]
MY;);)/XB\9^'?'GQ0U?Q)_:FD.;J[N; ^&_$?ARSM[K5+B]$UO%)I)806)#^
M%^&OV8?'6E?LU?LH_#.\\.>%D\8?!7XZ_"[QUJ]O'>Z8]EX>\.^%_BY=^)]?
MN/#6HK;!/M#^%KD06NFZ:EI)<12-I9.T&%_TA(CZ[5)R>@4G.1GWSE03_N^U
M V@C"8QP#M QU_(<G\SZFM)TY2DFG9*U];;.[_)?CW,5*2NU;5MO16N[[7VW
M=DMNFR&0J54$C&548Q@C:".?_K<8Z9'-?GK_ ,%&)#+^SUHTVPJLOQX_9[X)
MSM*?%[PUP3QG<"3VQCWX_1"O%OB_\'/#GQE\)V?@[QG'>3:'9^*O"WB^*WT[
M4)=.EDU?P=KMIX@T9I;J**5_LZ7UG"\L 4"8($8E-V<,PPDL=@<5A85%2J8B
M%.G"I))QCR8BAB)-WNK-8?DV>LU;NOI^!<\PG#'&O"W$684Z]; 9-G&'QN,I
M8:*GB)T(4<RIU8THMQO*2Q%**?,N5ZIIML];TXDVD992C%4RI.2I\M,@D<$C
MH>*\4_:%\*_%+Q?\.M6T3X0>);/PGXNN[_09EU*YM+F2:;3K37-)FU2VM+ZT
MU_P\^FSOIJ7FZX>>Z6[MDGTJ2W$5WYD?M>GF0VX\Y0LP)$H3/EB7 $@CSR4#
M[@O XQQ5T@'J ?J :[)6GS75E/F;5VFE)MVONK7M??3N?(X=.%##KWKPHT5[
M\5&=XT:4??@KJ,[I\\4VHSYHIM13/S8UW]F_XF:C^TMX6\8:?/K$O@'PQ\3;
M7X_^.[K5;?X7VWAWQW\4;+X$:Q\'+72?AY']K\1?%+2++5[#5]'75=.\7ZOH
MF@^&9- U/^PKWQ)IVO6^G:;%XN^"?Q?N/@9J'PVF^'=CXM\4?M(ZEXRUC]J7
MQ+X<UOP;9:AH&B^,M#CTC6_!G@.#Q5K>C6E[?1>#K?0_@QX2UO[6FG>'O#NB
MCQA=Q:EJ@MM+N_TLVK@C P1@C P1TP1Z8XQTIICC/!1"#G(*J>HP>W<<'VXZ
M5@L/",'"":3MJY2DU9WTE*[74Z'4F[7:]W;W8K[TE9_/LNB1^6G[5_[.OQY\
M;I8RZ#J>O^.]'_X1GXR^$O"VE^ 8OAK\/_%GPYTKXE>!]-\(Z9X.\0:OX_\
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M\^XAQ<\LISRZC0Q&+7[RI?VDDABCG5Y ,E%#$X)(SPN.H/?ISTYKB/$?Q0\
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MXM0\1>)=2$_V'2;2:]MM/AEN5MK>ZN-LMY=6]LHBMI7$DRY"J&=?RO\ C/\
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M:."<' X)Y.,#@<9QGC'49_#(7WQ U+XK_'[XB7WQ4^+L&L?"[_@IY^S3\(O
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MJR^&":7^U+\"+Z;XBZA9V6HV/@:.W\1WJR>)K_3M186-Y9Z6LIGGM[TI:2*
MEPZQN<CQ,%AI5WNJD::5G9N4X03:WLG+5W25KMI7:^BX*X>H<3\:\.\+XR=:
MAALYS&>"KUJ,:LJU*$<LSO'1J0C0P>85Y)5<LH*:H8'&5Y4:M6.'P];$2PU.
M?W?X$^(/A;QYX:TGQGX:U"[NO#NLVT\MA=ZAH^N:'<.MM<SVLK3Z7K^FZ5J]
MD1);3*!?Z?:O*JB9(DCDC+]:^M:6\64U"WQ(A:.0.?+90VTND@&QU#?*2K$
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MDY0GR5*E>I%U*;<J=10E5CRU:4FYTY:N,I7T=SLK;3H[8Q>6T:1Q(R+"D2[
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M_.OA?XW_ &N?'_PZ\ >']2\<^+O#NN^(_P!I/QMX%U?XLP?"6RNM8L_A!9?
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MM;B]\2^+[/QEX$DT2'6GU,ZKJ%]XIG\+_P!KV?\ :\W*>%OC;^VWK^A_&+Q
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MZB@!FP9XX'&??' ZY' X''3BE"X.=Q( ( )]<')]3QP3S@TZB@5MM]'=:O\
M'O\ .XC L" 2,XY&<XR">A!&1QG/&:8(\ _,Q_X$QS]222?3J#C/-244#&E<
MD<D #'!(_KC\P3Z$4BIM.202!M&!@8SG&,GOGGWI]% K>OWO_,:REEP6(Y!)
M7@D9SCOP1P:;Y8R3DY/ID ?09P#[CZG)J2B@?6_Z_IL0B$?Q/(QSUWN,^F0&
MP<?0#VZY4Q!L99N"3PS Y/<$'@>Q!%2T4#N^Y'Y?3#,"#DG/7Z^H/7KUH"8Q
M\QP#G'KSGDG)/MSQQC@8J2BC9WZL72W80J&&#^'M_4?@0?>C'3'&!COT'3H1
MTI:*223;MJ]^NV@6]?O9'Y?/WF/! !)X!Z]""2<#DGWZT\KD8)/U!(/!!ZY)
?[#///>EHI_=]PK>OWL0# Q_G_P"O]>IZFEHHH&?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
